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ABSTRACT 
 
 
Austenitic stainless steel designed for implant applications is used to fabricate balloon 
expandable coronary stents.  The alloy was not designed for this purpose but has been 
found to work well except for relatively low radiopacity in the energy range used for 
stent deployment, typically 80kV to 100kV.  Stents made of more dense elements such 
as tantalum exhibit high radiopacity in this energy range.  Low radiopacity is due to a 
combination of tubular stents having a thin wall (strut) thickness (less than 0.13mm) 
and the alloy being comprised of low-density elements, approximately 2/3 iron and 1/3 
chromium and nickel. To retain the desired thickness and increase radiopacity, alloy 
density may be increased by partial substitution with dense element(s).  The new alloy 
must maintain the biocompatibility, corrosion resistance, non-ferromagnetic structure, 
strength, ductility, and fatigue- and fracture-resistant characteristics that made the 
original alloy attractive to stent designers.  Coronary stents are subject to intensive 
review by regulatory authorities prior to being approved for human use, thus stent 
designers are hesitant to depart from accepted standards in selecting new alloys.  
Revising an existing alloy is the preferred approach to achieve subtle feature changes.  
A set of criteria was set that maintained chromium, nickel, and molybdenum within 
prescribed compositional ranges and diminished iron to its minimum level, allowing 
platinum to be substituted for approximately 1/3 the total elemental weight (wt%).   
Above 20wt% platinum, undesirable precipitates were found.  An alloy containing 
20wt% platinum, in the form of foil and at a thickness of 0.127mm, was found to be free 
of precipitates not found in the base or original alloy and to provide approximately 20% 
radiopacity increase at 80kV and 15% radiopacity increase at 100kV, exceeding 
minimum programme goals at 80kV and equaling those at 100kV. 
 iii
ACKNOWLEDGEMENTS 
 
This research was carried out while an employee of Boston Scientific Corporation’s 
(BSC’s) Cardiovascular Group and of Interventional Technologies, Incorporated (IVT), 
(acquired by BSC in 2001).  Thanks go to Dr. Robert Reiss (IVT) and Mr. Matthew 
Jenusaitis (BSC) for their support of this research, which began in July, 2000.  The idea 
for alloying austenitic stainless steel for fabrication of enhanced radiopacity coronary 
stents was jointly developed with the writer’s supervisor, Mr. Herbert Radisch, Jr., and 
with Dr. Thomas Trozera, P.E. (consulting engineer).  Support in alloy and radiographic 
development was provided by Mr. Edward Vesely, Jr. and his team at United States 
Department of Defence’s Advanced Materials and Processes Technology Information 
Analysis Centre.  Support in alloy development was provided by: Mr. Paul Turner and 
his team at United States Department of Energy’s Albany Research Centre; Mr. John 
McEwan and his team at South Africa’s Ministry of Minerals and Energy’s Mintek 
research facility.  Support in radiographic development was provided by: Mr. Keith 
Ingram, Centre for Radiographic and Medical Studies, Department of Materials and 
Medical Sciences, Cranfield University; Mr. Harold Berger and his team at Industrial 
Quality, Incorporated; Mr. Michael May and his team at Decisive Testing, Incorporated.  
For serving as academic advisors while studying at George Mason University: Professor 
Joseph Lieb and Dr. Peter Ceperley, College of Arts and Sciences; Dean Emeritus 
Gustavo Mellander, Graduate School of Education.  For serving as academic advisors at 
Cranfield Postgraduate Medical School: Professor Clifford Friend and Dr. Michael 
Edwards.  For serving as external advisors: Mr. Herbert Radisch, Jr., and Dr. Nev 
Gokcen.  Finally, the writer thanks his wife, Margaret Essig Craig, for her continued 
love and support for some 27 years, especially during the initial years of postgraduate 
study at Brunel University, shortly after their marriage, then at Cranfield University, 
and more recently continued at George Mason University and at Cranfield University, 
which together has provided an opportunity for and has culminated in this research. 
 iv
DEDICATION 
 
The writer dedicates this research to the memory of his mother, Edith Freeman Craig, 
whose premature death due to cardiovascular disease silenced forever her golden voice. 
 v
List of contents 
 
 
1 INTRODUCTION              1 
 1.1 Background            1 
 1.2 Emergence of radiographically-aided methods of vascular medicine     3 
1.3 Problem           12 
1.4 Administrative and economic concerns       13 
1.5 Objectives           16 
1.6 Thesis structure          17 
1.7 References          17 
2 ALLOY DESIGN           20 
 2.1 General           20 
 2.2 Objective, approach and supporting rationale      21 
 2.3 Maintain specification context        22 
 2.4 Increase overall radiopacity        24 
 2.5 Ensure no ferromagnetism        27 
 2.6 Freedom from inclusions or other deleterious phases     29 
 2.7 Mechanical properties         31 
 2.8 Corrosion           32 
 2.9 Summary           33 
 2.10 References          33 
3 EXPERIMENTAL DESIGN AND RESULTS       36 
 3.1 General           36 
 3.2 Increase Radiopacity         37 
 3.3 Maintain precipitate free austenitic structure      41 
 3.4 Strength predictions         51 
 3.5 Corrosion           52 
 3.6 Results           52 
 3.7 References          53 
4 EXPERIMENTAL METHODS AND RESULTS       55 
 4.1 Introduction          55 
 4.2 Conforming, proof-of-concept button melts (1-5wt% platinum)    57 
 4.3 Conforming, low-radiopacity button melts (0-10wt% platinum)    66 
 4.4 Non-conforming, high-radiopacity button melts (0-35wt% platinum)   83 
 4.5 Conforming, low-radiopacity, induction-melted alloys   106 
 4.6 Conforming, high-radiopacity, induction-melted alloy   115 
 4.7 References        120 
5 DISCUSSION OF RESULTS                  122 
6 CONCLUSIONS AND RECOMMENDATIONS     133 
 Conclusions         133 
 Recommendations for further work      135 
 
 vi
List of tables 
 
 
1.  Death rates from coronary artery disease for men  and women  aged 35-74       1 
 
2. Long-term goals and achievements of a government-led programme in the             2 
      United Kingdom to reduce deaths by coronary artery disease    
    
3. Stents proposed for implantation in Europe circa 1997                    10  
  
4. Quaternary alloy (Q) showing resultant radiopacity at 80keV (density, ρ, and  
      mass attenuation coefficient, µ/ρ, are from tables provided by Hubbell and  
      Selzer, 1997)              38 
 
5.  Quaternary alloy (Q) showing resultant radiopacity at 100keV (density, ρ,  
       and mass attenuation coefficient, µ/ ρ, are from tables provided by Hubbell and  
       Selzer, 1997)             38 
 
6. Calculated radiopacities for primary elements of UNS S31673 (t = 0.127mm)      38 
 
7.   Calculated radiopacities for radiopaque elements for pentanary alloy  
(t = 0.127mm)          39 
 
8. Pentanary alloy showing resultant radiopacity at 80keV (density, ρ, and  
      mass attenuation coefficient, µ/ ρ, are from tables provided by Hubbell and  
      Selzer, 1997)                        40 
 
9. Pentanary alloy showing resultant radiopacity at 100keV (density, ρ, and  
      mass attenuation coefficient, µ/ ρ, are from tables provided by Hubbell and  
      Selzer, 1997)             40 
 
10. New PHACOMP Md numbers            48 
 
11. Pentanary alloys using minimised quaternary plus element “X”                  49 
 
12. Body centred cubic elements tantalum and tungsten used to enhance  
      radiopacity of quaternary alloy shown in Table 4 and Table 5       50 
 
13. Hexagonal close packed elements rhenium and osmium used to enhance  
      radiopacity of quaternary alloy shown in Table 4 and Table 5       50 
 
14. Face centred cubic elements iridium, platinum, and gold used to enhance  
      radiopacity of quaternary alloy shown in Table 4 and Table 5       51 
 
15. Preliminary alloys containing platinum plus base UNS S31673 alloy (BioDur®  
316LS)                         57 
 
16. Preliminary alloys containing platinum plus base UNS S31673 alloy (wt%)          61 
 vii
17. New PHACOMP results for preliminary alloys containing platinum 
      (Md critical set at 0.920eV, 1100°C)        63 
 
18. Strength calculations for preliminary 0-5wt% platinum in UNS S3167    64 
 
19. Mechanical and physical property data for preliminary 0-5wt% platinum   65 
 
20. Pitting resistance equivalence number calculation for 0-5wt% platinum alloys    65 
 
21. Chemical composition of UNS S31673 and platinum-containing alloys,  
       0 - 10wt%           67 
 
22. UNS S31673 and platinum-containing alloys, 0 - 10wt%     68 
 
23. New PHACOMP results for UNS S31673 and platinum-containing alloys,  
      0 - 10wt% (Md critical set at 0.920eV, 1100°C)       70 
 
24. Strength calculations for UNS S31673 and platinum-containing alloys  
      (0-10wt%)            73 
 
25. Mechanical and physical property data for UNS S31673 and platinum- 
      containing alloys (0-10wt%)         74 
 
26. Pitting resistance equivalence number calculation for 5-6wt% platinum alloys    75 
 
27. Wide-beam (100kV) and single-beam (100keV) radiopacities for five alloys       82 
 
28. Wide-beam (100kV) and single-beam (100keV) radiopacities for five alloys       82 
 
29. Summary of 0wt% platinum and 10wt% platinum data for 0-10wt% alloys         83 
 
30. Composition of idealised 0-35 wt% platinum alloyed in UNS S31673     84 
 
31. Composition of idealised 0-35 wt% platinum alloyed in UNS S31673     85 
 
32. New PHACOMP results for optimised 0-35wt% platinum alloys with iron and  
      nickel diminishing as platinum content increases       86 
 
33. Composition of specimens containing 0-35wt% platinum using x-ray diffraction  
      and energy dispersive spectroscopy.          88 
 
34. New PHACOMP results for 0-35wt% platinum alloys       89 
 
35. Composition of Type A precipitate found in 0-15wt% platinum alloys              90 
 
36. Composition of Type B precipitate found in 0-20wt% platinum alloys                 91 
 
37. Composition of Type C precipitate found in 25wt% platinum alloy                      91 
 viii
38. Composition of Type D precipitates found in 25-35wt% platinum alloys             92 
 
39. Single-beam radiopacities for hypothetical 0-35wt% platinum alloys   101  
 
40. Single-beam radiopacities for actual 0-35wt% platinum alloys (t = 0.127mm)   102 
 
41. Thickness and density of 0-35wt% platinum specimens                                      103 
 
42. Wide-beam (experimental) and single-beam (single-energy) radiopacities         103 
 
43. Experimental results at 80kV normalised to 0.127mm thickness                         104 
 
44. Experimental results at 100kV normalised to 0.127mm thickness                       105 
 
45. Radiopacity of 0-35wt% platinum viewed as percent increase over base alloy   105 
 
46. Nominally 6wt% platinum enhanced radiopaque austenitic stainless steel  
      before  and after vacuum arc remelting                                                                110 
 
47. Composition of ingot IVT 37 and ingot IVT 38 (Covino, Craig et al, 2003)      111 
 
48. Composition of ingot IVT 66                  112  
 
49. Composition of ingot IVT 78 and ingot IVT 79                                                   112 
 
50. Pitting resistance equivalence number calculation for 5-6wt% platinum alloys  112 
 
51. Mechanical properties for ingot IVT 79 cold-rolled and annealed at 1050°C     114 
 
52. Metallurgical properties for ingot IVT 79 cold-rolled and annealed at 1050°C  114 
 
53. Composition of ingot BSC 83A, BioDur® 316LS, and ASTM F139-00            116 
 
54. Pitting resistance equivalent number for BSC 83A and BioDur® 316LS           116 
 
55. Intergranular corrosion susceptibility test results for BSC 83A                          116 
 
56. Mechanical properties of ASTM F139-00 compared to BSC 83A                      118 
 
57. Metallurgical properties of ASTM F139-00 compared to BSC 83A                   118 
 
58. BSC 83A elements as determined for the matrix by x-ray fluorescence (XRF)  
      and energy dispersive x-ray spectroscopy (EDS)                                                 119 
 
59. Average values of elements found in ingot BSC 83A precipitates                      119 
 
60. Composition of precipitates found in base alloy                                                  127 
 
 ix
61. Composition of Type C precipitates found only in 25wt% platinum alloy 127 
 
62. Composition of Type D precipitates found only in 25-35wt% platinum alloys 128 
 
63. Comparison of conforming alloys at 6wt% and 30wt% platinum 131 
 
64. Radiopacity increases for 20wt% and (equivalent) 32.5wt% platinum alloys       132 
 x
List of figures 
 
 
1. Basic angioplasty equipment and setup                 4 
 
2. Self-expanding Wallstent® deployment   6 
 
3. Profile of balloon-expanding Palmaz stent (a) undeployed and (b) deployed; 
      profile of (c) undeployed and (d) deployed Palmaz stent as mounted on  
      balloon along with its leading and trailing retainers   7
    
4. Schaeffler diagram (stainless steel welds)        29 
 
5. Iron-Tantalum Phase Diagram          41 
 
6. Iron-Tungsten Phase Diagram          42 
 
7.   Gold-Iron Phase Diagram          42 
 
8. Iron-Osmium Phase Diagram          43 
 
9. Phase Diagram            43 
 
10. Iron-Platinum Phase Diagram          44 
 
11. Nickel-Platinum phase diagram          45 
 
12. Chromium-Platinum  phase diagram         46 
 
13. Schaeffler diagram showing platinum and iridium as nickel equivalents  
      and tungsten and tantalum as chromium equivalents in pentanary, 
      versus quaternary          47 
 
14. Iron-Chromium binary phase diagram        49 
 
15. Vacuum arc button furnace used to cast small austenitic stainless steel ingots    58 
 
16. Two-high rolling mill used to hot-roll austenitic stainless steel plate   59 
 
17. Radiopacity increases for 20wt% and (equivalent) 32.5wt% platinum alloys  60 
 
18. Schaeffler diagram for preliminary alloys containing platinum    62 
 
19. Schaeffler diagram for UNS S31673 and platinum-containing alloys,  
      0 - 10wt%           69 
 
20. As-cast microstructure of 0wt% platinum showing cellular austenite and  
      skeletal ferrite .  Electrolytically etched in oxalic acid       71 
 xi
 
21. As-cast microstructure of 10wt% platinum showing cellular austenite and  
      skeletal ferrite .  Electrolytically etched in oxalic acid     71     
 
22. Annealed microstructure of 0wt% platinum sample showing equi-axed  
      grains of austenite.  Etched in Behara’s No. 3.                 72 
 
23. Annealed microstructure of 10wt% platinum sample showing equi-axed  
      grains of austenite.  Etched in Behara’s No. 3.        72 
 
24. 80kV x-ray spectra with and without half-value-layer filters    78 
 
25. 100kV x-ray spectra with and without half-value-layer filters    78 
 
26. Manufacturer-supplied characteristic curves for industrial and medical film       80 
 
27. (a) Bright field image of the 915°C anneal matrix for 12.5wt% platinum alloy  
      (light  line is 1 micron), (b) corresponding microdiffraction pattern, and 
      (c) microdiffraction pattern for Type A precipitates                                             93 
 
28. Energy dispersive x-ray spectroscopy spectra for 915°C anneal 12.5wt%  
      platinum alloy. Typical (a) matrix; (b) Type B precipitate, and (c) Type A 
       precipitate             94 
 
29. (a) Bright field image of the 1100°C anneal matrix for 12.5wt% platinum alloy 
      (light line is 1 micron), (b) corresponding microdiffraction pattern, and 
(c) microdiffraction pattern for Type B precipitates  95 
 
30. Energy dispersive x-ray spectroscopy spectra for 1100°C anneal 12.5wt%  
      platinum alloy. Typical (a) matrix, and (b) Type B precipitate              96 
 
31. (a) Bright field image of Type C (rod-like precipitate at upper left) and Type D 
      (irregular-shaped) precipitates in 25wt% platinum alloy  (915°C anneal)(1  
      micron line); microdiffraction patterns for (b) matrix, (c) Type C and (d)  
      Type D precipitates         97 
 
32. Energy dispersive x-ray spectroscopy spectra for 25wt% platinum in  
      UNS S31673 alloy (915°C anneal).  (a) matrix; (b) Type C, and (c) Type D 
precipitates           98 
 
33. (a) Bright-field image of 915°C matrix and Type D precipitates in 35wt%  
      platinum alloy (bar is 1micron) and corresponding microdiffraction patterns  
      for (b) matrix, and (c) Type D precipitates      99 
 
34. (a) Bright-field image of 1100°C matrix and Type D precipitates in 35wt% 
      platinum alloy (bar is 1micron) and corresponding microdiffraction patterns  
      for (b) matrix, and (c) Type D precipitates     100 
 
 xii
35. Block diagram of optimum alloy-foil production process             107 
 
36. Typical vacuum induction melting furnace stainless steel ingot and crucible     109 
 
37. Stress-strain curve for ingot IVT 66 (annealed at 1050°C); and BioDur®  
       316LS base (annealed at 1050°C and water quenched)              113 
 
38. Typical surface of BSC 83A after corrosion susceptibility tests                         117 
 
39. Stress-strain curves for BSC 83A and BioDur® 316LS              117 
 
40. Energy dispersive spectroscopy spectra for ingot BSC 83A matrix            119 
 
41. Energy dispersive x-ray spectroscopy spectra for ingot BSC 83A precipitates   120 
 
 
 
 
 
 xiii
Chapter 1 
INTRODUCTION 
 
1.1 Background 
     Diseases of the heart and circulatory system, or cardiovascular disease, are the 
leading cause of death in the United Kingdom and also in the United States, where 
cultures are similar; over one in three deaths (40% and 39%, respectively) are caused 
by this disease (Petersen et al, 2003; American Heart Association, 2003).  With a 
population of almost 60 million, 240,000 died in the United Kingdom in 2001 due to 
this disease; in the United States, with a population 4.7 times greater, 945,000 died.  
Over 50% of all cardiovascular deaths in these two nations are due to coronary artery 
disease.  Table 1 shows that while these figures are less than in several nations, they 
also are more than in some others; miscoding of cause of death, e.g., in Japan, may 
account for variations of up to 30% in Table 1 data (Lozano et al, 2001). 
Table 1 Death rates from coronary artery disease for men (left) and women (right)  
aged 35-74 (1998)( Petersen et al, 2003) 
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      Through the World Health Organisation, governments of most nations are aware of 
the underlying causes of coronary artery disease.  In the United Kingdom, there is a 
concerted effort, led by government agencies, to reduce the toll of what are known as 
premature deaths, i.e., deaths of persons under the age of 75 years.  Table 2 shows the 
results achieved since 1970 and the goals for continued reductions in premature deaths. 
Table 2 Long-term goals and achievements of a government-led programme in the 
United Kingdom to reduce deaths by coronary artery disease (Petersen et al, 2003) 
 
 
 
 
     The battle against needless loss of life due to coronary artery disease is fought in 
many quarters and by persons of many and varied skills.  Cardiologists are assisted by 
other medical specialists, including medical physicists and radiologists, who aid in 
presenting and interpreting radiographic images, for instance.  These images allow 
visualising the beating human heart to facilitate diagnoses and to aid in its repair.  In 
attendance also are scientists, engineers, designers and fabricators of medical devices, 
integral team members in identifying or responding to needs for new or improved tools. 
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1.2 Emergence of radiographically-aided methods of vascular medicine 
1.2.1 Angiography      
     In experiments with the Hittorf-Crooks tube in 1895, Roentgen discovered ionising 
electromagnetic radiation, later described as Roentgen or x-rays.  Within a few weeks, 
Roentgen used x-rays to produce a ‘photograph’ of his wife’s hand (Abrams, 1997).      
Also within a few weeks of Roentgen's discovery, Abrams noted, a ‘roentgenogram’ of 
an amputated hand was described, which showed that Roentgen’s technique could be 
used to visualise the vascular bed when injected with a contrast agent (e.g., iodine, 
which, like barium, has a high x-ray absorption coefficient, making it ‘radiopaque’).  
After initial applications only to the study of cadavers, such techniques were applied to 
patients as a medical diagnostic tool that subsequently became known as angiography.   
     The emergence of angiography, which began with studies to understand the human 
vascular system, eventually, according to Abrams, led to angiographic techniques that 
included studies of the heart.  Cope and Baum (1997) noted that angiography requires 
the use of a catheter and a guidewire to deliver a radiopaque contrast agent to the site 
being diagnosed to achieve good definition of the ‘luminal surface’ of the blood vessel.  
Bettman (1997a) summarised the history and chemistry of contrast agents for 
angiography and the adverse reactions these may cause; he noted (1997b) that use of 
iodinated radiopaque contrast agents was preferred for most angiographic applications. 
1.2.2 Angioplasty 
     Becker and Waller (1997) described Gruentzig's balloon angioplasty procedure (or 
‘intervention’), circa 1978, which was used to enlarge a diseased lumen and improve 
flow beyond the lesion.  This was based on the Dotter-Judkins method (Dotter and 
Judkins, 1964), which used coaxial dilators, whilst continually visualising the 
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intervention angiographically.  The term that emerged to describe such interventions 
was percutaneous transluminal angioplasty; however, for treatment of coronary artery 
disease, a complementary term emerged to describe such interventions: percutaneous 
transluminal coronary angioplasty.  Becker and Waller noted that between 1980 and 
1987 much research was conducted on the effects of both percutaneous transluminal 
angioplasty and percutaneous transluminal coronary angioplasty.   Myler (1997) has 
provided an historical perspective on percutaneous transluminal angioplasty (which he 
simplified to ‘peripheral angioplasty’) and percutaneous transluminal coronary 
angioplasty (simplified to ‘coronary angioplasty’), noting the 1956 Nobel Prize in 
Medicine went to Cournand, Forssmann, and Richards for discovery of cardiac catheters 
and the application of catheterisation to cause pathological change in vascular systems.  
 
     Figure 1 shows a typical basic angioplasty equipment and setup.  At the centre of 
 
 
Figure 1 Basic angioplasty equipment and setup (Safian, 1997) 
 
the diagram are two adaptors, typically termed ‘Y sites’, one horizontal and one vertical.  
To the left of the horizontal Y site in this diagram are the arterial sheath, guiding 
catheter and the dilation balloon.  The coronary guidewire protruding from the guiding 
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catheter just beyond the dilation balloon can be seen traversing the two Y sites, ending 
in a manually-operated steering tool.  At the juncture of the horizontal Y site and to the 
top right can be seen the hand-held manipulator and four-way manifold that is used to 
inject radiopaque contrast agent or saline solution, monitor blood pressure, and allow 
for the escape of waste fluids.  To the right of the vertical Y site is the inflation tool 
used to pressurise the dilation balloon. 
     As summarized by Becker and Waller (1997), various pathophysiologic mechanisms 
were revealed by use of peripheral angioplasty and coronary angioplasty.  The primary 
concerns that resulted from such use were fracture of the plaque that was the source of 
the constriction in the blood vessel, and how that fracture manifested itself during the 
subsequent weeks or months.  It was found that while fracture was necessary there was 
the possibility of too much fracture, termed ‘over-injury’, which might result in 
restenosis, which these authors described as regrowth or occlusion in the area where 
compressional methods were applied to the lumen (from within).  Becker and Waller 
have indicated they consider restenosis to be the principal negative after-effect from the 
application of either peripheral angioplasty or coronary angioplasty.   
1.2.3 Stents 
       A stent, named after medical devices pioneered by a British family of dentists by 
that name and re-applied during the past two decades, is a cylindrical device intended to 
provide mechanical support radially to weak or diseased blood vessels in order that 
vessel patency is enhanced.  Balcon et al (1997) and Wong and Schatz (1993) described 
the history of stent development, noting the term ‘stent’ was based on work of the 19th 
century dentist Charles Stent and his two sons, also dentists, who developed a dental 
apparatus to support misaligned teeth; the term was subsequently applied to any medical 
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device that supported a body cavity during surgical procedures for skin grafting.  
According to Balcon et al, Charles Dotter, an interventional radiologist, appeared to 
have used the term ‘stent’ first for a vascular implant when he reported an early 
application (Dotter, 1969).  Dotter is sometimes referred to as the ‘father’ of stenting. 
     The first coronary stent was implanted in a human body in 1986 by Puel, in France 
(Rousseau et al, 1987; Sigwart et al, 1987).  Figure 2 shows this self-expanding mesh 
stent, Boston Scientific Corporation’s Wallstent®.  Originally made of stainless steel, it 
is made from a cobalt-based alloy wire with a platinum core for enhanced radiopacity.  
Three views of the Wallstent® are shown in Figure 2 as (a) it is initially mounted on the 
delivery device, (b) it is partially deployed as the stent begins to expand on being 
released from its sheath, and (c) it is fully deployed or implanted within the artery. 
 
Figure 2 Self-expanding Wallstent® deployment (Safian, 1997) 
 
     A first balloon-expandable stent was described by Palmaz et al (1985); Figure 3 
shows profiles of the undeployed and deployed austenitic stainless steel mesh stent and 
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part of the deployment apparatus.  In Figure 3(a) a section of the compressed stent is 
portrayed; in Figure 3(b) a comparable section of the fully-expanded (deployed) stent is 
portrayed.  Figure 3(c) portrays the stent mounted on its dilation balloon, along with its 
guiding catheter and guidewire, here described in a more detailed view as ‘leading and 
trailing retainers’; Figure 3(d) provides a similar view for the deployed stent as it would 
appear on a fully-inflated dilation balloon. 
 
Figure 3 Profile of balloon-expanding Palmaz stent (a) undeployed and (b) deployed; 
profile of (c) undeployed and (d) deployed Palmaz stent as mounted on balloon along 
with its leading and trailing retainers (Kutryk and Serruys, 1999) 
 
    It was not until the mid-1990s that, according to Balcon et al (1997) and Kutryk and 
Serruys (1999a), results of stents, as compared to results from angioplasty, indicated 
that stents decreased restenosis and improved patient outcomes.  Becker and Waller 
(1997) noted that in three month follow-up angiograms, use of vascular stents resulted 
in a greater lumen diameter, even with the onset of restenosis.  Kutryk and Serruys 
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(1999b) have argued that coronary stents may be the most important advance in the field 
of cardiology since the introduction of coronary angioplasty.  The extensive literature 
reviewed by Balcon et al (1997) describes the emergence of a new and important 
technology that was almost lost because of a misunderstanding of outcomes of early 
trials and because of an editorial that sensationalised the negative results from the trials.   
     As inferred above, stents are extremely simple mechanical devices designed to open 
closed or restricted arteries and keep them from closing again.  Stents act as a 
cylindrical scaffold once they are in place and expanded, or deployed, to the required 
diameter.  Stents may be used in the arteries of the heart, where they are referred to as 
‘coronary’ devices, or elsewhere, where they are referred to as ‘peripheral’ devices.   
     A coronary stent is permanently implanted in the native or grafted vasculature of the 
heart in an attempt to return the flow of blood in an artery to its normal rate at the lesion 
where the stent is deployed.  Such interventions are conducted by an interventional 
radiologist or an interventional cardiologist; the term ‘interventionalist’ is often used.  
Use of stents allows cardiologists to make this intervention in a manner that may 
obviate the need for performing open heart surgery.  Open heart surgery places the 
patient at greater risk and may subject him to discomfort and to a lengthy hospital stay. 
     Coronary stents are meant to fit neatly inside the blood vessels as they traverse the 
sometimes tortuous paths to the desired location.  The interventionalist would insert a 
catheter by inserting a stent, located on a guiding catheter similar to that used for 
angioplasty, into a blood vessel through the patient's groin and manoeuvre the stent into 
an appropriate point in his heart and then into a clogged portion of the artery.   In either 
mesh or mesh-like geometries, the stents are initially collapsed, which minimises the 
diameter and provides flexibility to the interventionalist in negotiating complex 
 8
pathways into and through myriad vascular branches within the heart and then to the site 
of a weakened or diseased coronary artery.   
     Once at the desired location, either a sheath is removed to allow a self-expanding 
stent to open or a dilation balloon is inflated via access through the guiding catheter.  
The mesh or mesh-like geometry of the stent then opens or expands, taking advantage 
of both the ductility of the metal or alloy selected and a relatively weak structure caused 
by the finely woven wires of a mesh or their equivalent, struts (when made from tubes).  
After the stent has been deployed to the desired diameter it retains sufficient strength as 
a tubular structure to withstand the radial forces on it and maintain its shape without 
collapsing.   
     A stent working group report on coronary circulation (Balcon et al, 1997) provided a 
list of tests the group determined both stents and stent materials should be subjected to.  
For stents, the list included (a) radial strength, (b) fatigue testing, (c) elastic recoil,      
(d) Magnetic Resonance Imaging testing,  (e) expansion (by plastic deformation), and 
(f) surface characteristics.  For stent materials, the list included (a) material analysis, (b) 
mechanical properties testing, and (c) corrosion testing.  Table 3 provides a list of self-
expanding and balloon-expandable coronary stents proposed or available for use in 
Europe circa 1997 (Balcon et al, 1997).   
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Table 3 Stents proposed for implantation in Europe circa 1997 (Balcon et al, 1997) 
 
 
     Serruys (1997) carried reviews by various authors of a total of 21 stents in his initial 
stent ‘handbook’ (currently in its 4th edition, Serruys and Rensing, 2001).  In both these 
reports, well over half of the balloon-expandable stents were made of stainless steel, 
while the remaining stents were comprised of a variety of metals, e.g., single elements 
(tantalum), binary alloys (platinum-iridium; nickel-titanium), and composites (cobalt 
alloy with platinum core).  The stainless steel chosen for the stents reviewed by Balcon 
et al was not reported, but in all cases reported by Serruys (1997), the alloy was a 
variant of an implant-grade molybdenum-containing austenitic stainless steel, which has 
a long history of use within the human body.  This is because this implant-grade alloy 
has good biocompatibility, corrosion and pitting resistance, strength and ductility, and, 
particularly important with coronary stents, it is not ferromagnetic.  As noted by Balcon 
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et al, there is concern about exposure to magnetic resonance imaging.  More recently, 
with the advent of magnetic resonance angiography, remnant ferromagnetism is of 
concern since high strength magnetic resonance imaging and magnetic resonance 
angiography fields may displace or remove a deployed coronary stent. 
     As with contrast agents, the radiopacity of a stent is dependent upon the x-ray mass 
attenuation coefficient of the element or elements the stent is made from, the density of 
the element or elements it is made from, and the strut thickness.  However, as stents are 
made thinner they become increasingly less radiopaque and thus less visible 
radiologically to the interventionalist.  As strut size is decreased to make the stent more 
flexible and more capable of being used in smaller vessels and through more tortuous 
paths, it becomes a matter of assuring not just flexibility but that sufficient structural 
strength exists to prevent collapse of the stent under load.   
     The single through-wall (strut) thickness of the stainless steel stents described in 
Serruys (1997) varied from a low of approximately 0.070 mm to a high of 
approximately 0.200 mm.  Thus the optimum thickness, from a mechanical point of 
view, may be about 0.070 mm or, possibly, even less.  Extremely thin stainless steel 
stents are quite difficult to visualise whilst being deployed, most often requiring use of 
radiopaque markers on the balloons or on the stents themselves.  Finding such thin 
stents after deployment is of concern, as well, since periodic checks are made, 
particularly in the early weeks after the stent deployment, to be sure it had not somehow 
moved to another location, leaving the diseased vessel without the required assistance 
provided by the deployed stent.  
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1.3 Problem
     The interventionalist must be able to visualise continually the stent and its 
surroundings via real-time radiology both whilst it is being deployed and subsequently.  
In addition to the radiopaque contrast agent, the interventionalist is often aided by 
radiopaque marker bands on the dilation balloon that effectively allows the location of 
the two ends of the stent to be determined; these thin marker bands are typically made 
of Period 6 elements such as tantalum, platinum, or gold, which have high x-ray mass 
attenuation coefficients at the x-ray energies typically used and also are quite dense.  
The stent itself is often invisible or nearly so due to a combination of factors.  These 
factors include: the absorption coefficients and densities of the elements comprising the 
stent and the surrounding tissue and bone, the thickness of the stent (i.e., wire or strut 
size) and those of its surroundings, as well as the ability of the x-ray imaging system to 
detect the transmitted photons and present an image of the stent and its surroundings to 
the interventionalist.  From time to time, the area being imaged may be flooded with a 
contrast agent to aid in stent visualisation but, as with the radiopaque markers on the 
dilation balloon, this only occurs during the initial stent deployment stage.  If it is 
necessary to review the condition of the deployed stent or to return to the site of the 
deployed stent at some later time to either cross over or deploy another stent, it is 
important to the interventionalist that the precise location and condition of any 
previously deployed stents be fully determined before attempting such procedures. 
     Since the tortuous path involved in deploying a stent demands the ultimate in 
flexibility, the thin structure of the stent must remain largely as presently designed and 
in effect only the densities and absorption coefficients of the elements used to make the 
stent lend themselves to change.  While stents made from both nickel-titanium shape 
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memory alloys (typically used for self-expandable stents) and austenitic stainless steels 
(typically used for balloon-expandable stents) could benefit from increased densities 
and x-ray absorption coefficients, only austenitic stainless steel will be considered here 
since the two alloys differ radically in chemical composition and since sponsorship for 
this research was principally in support of development of new stainless steel stents. 
     The problem to be addressed, then, is that implant grade austenitic stainless steel, 
when used as a coronary stent, does not exhibit sufficient radiopacity to allow the stent 
to be optimally visualised either during or after deployment.  The principal elements of 
austenitic stainless steels are iron, chromium, and nickel, all of which are located in 
Period 4 of the periodic table of the elements and thus substantially less dense and with 
much lower x-ray absorption coefficients than, e.g., the elements used for radiopaque 
markers (tantalum, platinum, or gold).  From this analysis, it is clear that the poor 
radiopacity of stents made from austenitic stainless steel is due to thin sections (struts), 
to being comprised of low density elements, and to low x-ray absorption coefficients.   
1.4 Administrative and economic concerns
     The radiopacity of those few austenitic stainless steels that are commercially 
available for use as surgical implants is not a consideration in most applications of such 
alloys.  Coronary stents are an exception to this rule because their mass is quite small, 
they are to be embedded in the arteries of the human heart within a closed chest cavity, 
and the interventional cardiologist treating the patient desires to use radiographic 
imaging to visualise the area of the diseased artery in need of repair whilst visualising 
the stent somewhat as a phantom, which should be seen without obscuring the 
interventionalist’s view of the diseased artery.  Alternative materials such as the nickel-
titanium shape memory alloys are somewhat less radiopaque than stainless steels, while 
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other alternatives such as tantalum may be overly radiopaque for such an application.  
Fabrication of stents from composites of radiopaque elements sandwiched in or on 
alloys made of less-radiopaque elements may create additional design and processing 
difficulties, e.g., radiopaque coatings tend to be brittle and may spall off when balloon-
expandable coronary stents are plastically deformed, as they must be once they are 
located in the portion of the diseased artery in need of bridging or shoring up in 
deploying the stent.  Radiopaque wires, such as are created by inserting platinum wire in 
tubes and the two drawn to create a more radiopaque wire, are best for woven stents. 
     In critical applications of structural alloys where human lives may be endangered, 
regulatory bodies typically exist, often implementing their own or consensus standards 
that reflect attempts by both the regulated industry and the regulatory body to support 
the needs of the application by developing alloy specifications that meet most needs.  
Subsequent tailoring of a standard alloy to unique needs such as increased radiopacity 
may depart from the standards and require the proposed user to approach the regulatory 
body for approval prior to implementing use of the revised alloy in critical applications. 
     Taking a first-principles approach to designing and developing a radiopaque alloy 
that also meets the accepted standard for austenitic stainless steel for surgical implants 
would be an arduous undertaking for a person or entity representing user organisations 
such as coronary stent designers or fabricators.  The emphasis within alloy research and 
development organisations for such efforts is typically for critical applications where 
the expected sales volume of the resulting product is sufficient to justify the investment.  
With the minimal amount of material currently used in manufacture of coronary stents, 
approximately 0.8 mg/mm of length, as compared, e.g., to hip and knee replacements, 
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the stent industry has been largely left on its own to devise solutions to the problem of 
poor radiopacity upon choosing austenitic stainless steel, the issue being addressed here. 
     Tailoring an existing implant-grade austenitic stainless steel to improve radiopacity 
while maintaining adherence to the published specifications accepted by the regulatory 
bodies would be the ideal solution, it would appear.  However, the difficulty with such 
an approach is that the specifications are typically written in such a manner as to 
prevent the addition of unspecified additional elements, thus causing the alloy to be 
considered non-compliant.  However, submitting details of the modification with its 
performance characteristics to the regulatory body to gain approval for use may be the 
solution that has the most near-term viability in addressing the radiopacity problem. 
     In addition to the important economic and administrative problems that set the scene 
for a technical solution to a radiopacity problem with implant-grade austenitic stainless 
steels, defined above, there are technical issues to be addressed.  One of the most critical 
issues is maintaining a non-magnetic alloy because of the dangers inherent in utilising 
ferromagnetic materials as implants when potentially within the strong fields of 
magnetic resonance imaging or magnetic resonance angioplasty systems; the risk to the 
patient is great if the coronary stent shifts or is removed, which could occur if the alloy 
is not substantially free of ferromagnetic phases at the temperature of the human body.  
A second issue is multi-pronged but essentially reduces to one of corrosion of the alloy 
within the environment of the body and one of biocompatibility of the resulting alloy.  
Many other issues abound; these include strength and ductility and freedom from the 
deleterious phases and compounds that may change fracture or fatigue characteristics.  
These issues can be addressed in part by the administrative approach outlined above, 
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addressing the changes required to increase alloy radiopacity within the context of the 
very criteria that was applied in developing compliant alloys. 
1.5 Objectives
     The intrinsic features of the implant grade austenitic stainless steel, e.g., its 
biocompatibility, corrosion resistance, strength, ductility, and relative freedom from 
deleterious phases that might contribute to fracture or fatigue failures are such that it is 
considered quite desirable by stent designers to maintain those features largely as they 
are.  Because of this, only those modifications are considered that affect an increase in 
overall alloy density and concurrent increase in x-ray absorption coefficient that in turn 
will lead to the fabrication of a more radiopaque austenitic stainless steel coronary stent. 
     The approach taken is to add a single high-atomic-number element to a 
commercially-available implant grade austenitic stainless steel to increase overall alloy 
density and x-ray absorption coefficient of the resultant enhanced-radiopacity alloy.  
This is meant to ensure the desirable features of implant grade alloy are retained, to the 
maximum degree possible, and also that established specification guidelines are met as 
much as possible; this allows delays in developing, testing, and manufacturing a new or 
modified alloy to be minimised and, possibly, a shortening of the review and acceptance 
process of such a new or modified alloy as demanded by regulatory bodies. 
     The objective is to develop an enhanced radiopacity austenitic stainless steel stent 
that is approximately 15% greater in radiopacity at 80kV and 100kV radiation than the 
standard implant grade stainless steel being used for manufacture of coronary stents in 
the United Kingdom and the United States.   
     The goal, in short, is to complete the initial proof-of-concept phase required to 
provide stent designers an austenitic stainless steel that may be viewed as largely 
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unchanged except that it provides substantially enhanced radiopacity as made into a 
coronary stent. 
1.6 Thesis structure
 Chapter 2 is a somewhat more detailed continuation of this introductory chapter, in 
order for the reader to understand the requirement for, evolution and application of 
coronary stents made of implant grade austenitic stainless steel.  Chapter 3 is focussed 
on the alloy development process and on both the calculation and quantitative 
determination of radiopacities.  Chapter 4 is focussed on applying the underlying 
theories and requirements described in Chapter 3 through experimentation to gain 
results necessary to prove or bring about the required changes described in Chapter 3. 
Chapter 5 discusses these results, and is followed by Chapter 6, in which conclusions 
are drawn from the results obtained and recommendations are made as to further work.   
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Chapter 2 
ALLOY DESIGN 
 
2.1 General 
      Stainless steel is offered in various sub-categories (grades) that have evolved in 
order to fit particular applications.  Among the available grades are the austenitic alloys, 
which are face centred cubic and non-magnetic.  These alloys are typically made of 
approximately 2/3 iron to 1/3 chromium and nickel, with minima on chromium and 
nickel set at 10-11 weight percent (wt%) and 8wt% respectively.  Molybdenum in small 
amounts is sometimes added to iron-chromium-nickel ternary alloys to minimise pitting.   
     A less-used alternative to produce austenitic stainless steel is to minimise nickel 
content and use relatively large amounts of manganese and nitrogen.  Such alloys 
exhibit certain advantages, particularly cost, but these advantages are usually 
accompanied by higher strength and attendant reduced ductility, considered 
disadvantages for applications such as balloon-expandable coronary stents.  Other 
available grades include ferritic and martensitic stainless steels, which are magnetic.  
Processing an austenitic stainless steel may result in too much ferrite as it is cooled from 
the austenite phase or mechanically-induced strains may convert it to martensite.   
     Typical stainless steels contain up to 0.08wt% carbon, while ‘low carbon’ alloys are 
usually limited to 0.03wt% carbon.  Low-carbon austenitic stainless steel is often 
chosen when welding, laser cutting, or using other elevated temperature processes.  This 
is because at higher temperatures carbon combines with chromium and precipitates as 
carbides onto the grain boundaries, leaving the austenite grains with lowered chromium 
and the alloy subject to intergranular corrosion.   
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2.2 Objective, approach and supporting rationale 
     The objective, as stated in §1.5, is to develop an enhanced radiopacity austenitic 
stainless steel stent at least 15% greater in radiopacity at 80kV and 100kV radiation than 
stents made from alloys now available; ideally, radiopacity would be increased by 30%. 
     In §1.5, it was noted that a multi-pronged approach to alloy design will be taken.  To 
increase radiopacity, the overall density and x-ray absorption coefficient of an existing 
austenitic stainless steel will be increased.  To ensure the resulting alloy retains the 
desirable features of the base alloy as much as possible, a commercial alloy will be re-
melted and a single, high-atomic-number dense element added.  Any required elements 
will be replenished, as necessary, such that the resulting enhanced-radiopacity alloy 
conforms to the maximum extent possible to the established specification guidelines for 
the base alloy from which it is derived.   
     In §1.2, the results of a working group on stents and stent materials were discussed 
(Balcon, 1997).  The list of materials-related issues in the working group report 
included (a) material analysis, (b) mechanical property testing, and (c) corrosion testing.  
Stent-specific issues in the working group report indicated concerns about 
ferromagnetic phases, which must be minimised in austenitic stainless steel, as noted 
above; the interaction of remnant ferromagnetism with the strong fields of magnetic 
resonance imaging and magnetic resonance angiography are of concern.  The list 
included (a) hoop strength, (b) fatigue testing, (c) elastic recoil, (d) expansion by plastic 
deformation, and (e) surface characteristics.  Together, and broadly, these features argue 
for an alloy that exhibits biocompatibility, strength and ductility, and freedom from 
embrittling phases or inclusions that contribute to fracture, fatigue or corrosion failures.   
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     The small quantities of raw material required for fabricating coronary stents have 
until now led the medical device industry to utilise available, implant-grade alloys 
rather than have those tailored to the unique needs of the industry by metal suppliers; 
with the exception of providing adequate radiopacity, this has worked relatively well.  
Adding radiopaque coatings to stainless steel has been accomplished but, when 
compared to the potential to utilise a somewhat similar alloy with greater radiopacity, 
e.g., implant grade cobalt-based alloys containing high-atomic-number elements, 
tantalum or tungsten, the engineering mechanics aspects of utilising a single alloy for 
this application versus a composite argue strongly in favour of the former approach. 
     In sum, there is the matter of tailoring a general-purpose implantable alloy to the 
specific needs of coronary stents without losing the key advantages of the base alloy.  
There are obviously regulatory issues to be concerned with; these must be addressed as 
the plan is made and, in the long term, brought to fruition.  The key technical attributes 
to be addressed can be summarised as follows: 
• Enhanced/increased radiopacity of the component part (stent)  
• Absent or fully minimised ferromagnetic phases (ferrite; martensite)  
• Absent/minimised potentially embrittling phases (intermetallics, inclusions, etc.)  
• Mechanical properties (strength, ductility) comparable to those of current alloys 
• Equal/equivalent corrosion properties as determined by standard test methods 
2.3 Maintain specification context 
     Two contextually identical specifications that may be used to govern composition 
and material properties of implant-grade austenitic stainless steels are those published 
by International Standards Organisation (ISO 5832-1:1997) and The British Standards 
Institute (BS 7252-1:1997).  These specifications describe an alloy, Composition D, 
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which while not specially designed for this application, has been widely used for 
fabricating coronary stents.  The former American Society for Testing and Materials 
(now ASTM International) chairs the International Standards Organisation working 
group responsible for maintaining ISO 5832-1 but both its recently-balloted equivalent 
specifications, ASTM F138-03 (bar) and F139-03 (sheet), as well as the earlier F138-00 
and F139-00, were published after the International Standards Organisation and British 
Standards Institute.  ASTM F138 and ASTM F139 include minor modifications that 
have not yet been incorporated into BS 7252-1 or ISO 5832-1.  ASTM International 
does not utilise the ‘Composition D’ terminology but a somewhat simplified approach 
that incorporates older systems, which is described in one of its standard practices, 
ASTM E527-83(1997)E1; this is the ‘unified national standard’ (UNS) naming scheme.  
Under ASTM E527, both ASTM F138 and ASTM F139 alloys are alloy UNS S31673, 
where the ‘S’ is for stainless steel, the ‘316’ indicates a family of austenitic alloys 
containing iron, chromium, nickel and molybdenum, and the ‘73’ uniquely identifies the 
compositional range of alloys described in ASTM F138 and ASTM F139.  Any 
intentional addition of elements not within the scope of the Unified National Standard 
designation would necessitate application for and eventual issuance of a new UNS 
S316xx designator, provided that iron remained the primary element and that 
chromium, molybdenum, nickel, and carbon remained within the scope of the UNS 
S316xx alloys.  New standards specifying composition and properties of such an alloy 
would be required to be written, vetted, and approved by the issuing authority if the 
alloy is to be offered commercially. As an example, in the event of presenting the case 
for a new alloy standard to ASTM International Committee F04 (Medical Devices and 
Services), Subcommittee F04.12 (metallurgy) would establish a task group to 
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investigate the need for and, if appropriate, draft the standard for balloting.  ASTM 
International Committee F04 might then propose the newly-approved standard for 
consideration by International Standards Organisation, which might then be included in 
ISO 5832-1.  ASTM International works closely with the American regulatory authority 
for medical devices, United States Food and Drug Administration, such that ASTM 
International Committee F04 consensus standards effectively serve as Federal standards 
once they have been balloted and approved for use.  In the absence of such a new 
standard, or while preparing such a standard, individual companies may petition 
regulatory authorities (e.g., United States Food and Drug Administration) for 
permission to utilise what is termed a ‘non-compliant’ alloy design, much as companies 
might petition regulatory agencies for approval of any other design change that does not 
radically depart from the original design and relates to the risks involved in the 
proposed human use of a medical device. 
     UNS S31673 alloys described in ASTM F138 and ASTM F139 are low-carbon, 
austenitic, molybdenum-containing stainless steels comprised of, at minimum, the 
interstitial non-metal, carbon (limited to 0.03wt%), and the four substitutional transition 
metals, chromium (17-19wt%), nickel (13-15wt%), molybdenum (2.25-3.0wt%), and 
iron (balance).  Under ASTM E527, iron must be the predominant element for an alloy 
to be defined as steel.  Other elements, along with their limits, as specified in ASTM 
F138 and F139, are manganese (2.0wt%), phosphorous (0.025wt%), sulphur 
(0.010wt%), silicon (0.075wt%), nitrogen (0.10wt%), and copper (0.50wt%).   
2.4  Increase overall radiopacity 
     The desired increases in radiopacity for an implant-grade austenitic stainless steel, 
here the UNS S31673 alloy, as determined by balloon-expandable coronary stent 
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developers, are at least a nominally 15 percent increase and, ideally, nominally 30 
percent, compared against the existing alloy at 80-100kV at a thickness t of 0.127mm. 
     The adjective, radiopaque, and its noun, radiopacity, are somewhat unfamiliar terms 
to the metallurgist and industrial radiographer because radiographic methodology in 
industry developed almost entirely from a technology where transparent-base 
radiographic film densities were measured and compared to determine quality and 
sensitivity using image quality indicators (also called radiographic penetration meters, 
or penetrameters) that are placed on or near the item being inspected (Halmshaw, 1971; 
Berger, 1985).  In industrial radiography, the visibility of what is sometimes referred to 
as a ‘foreign object’ such as an inclusion of a particular size may be the objective, thus 
the ability to distinguish between the transmission density of the penetrameter placed on 
the surface of the material and the transmission density of the adjacent material, as well 
as the ability to distinguish between certain wires or holes in the penetrameters, are used 
for the radiographic film interpreter to gain confidence in his ability to locate and 
identify the inclusion, if present.  Considering the human body as a composite material, 
the visibility of the stent, a ‘foreign object’ within its surroundings, is here the objective. 
     Transmission film density (D), or light absorbance, is typically determined with a 
calibrated densitometer that takes the common logarithm of the ratio of the intensity of 
light entering (Ie) the radiographic film versus the intensity of light exiting (It) the film, 
shown in the following equation (American Society for Metals, 1976): 
Transmission Film Density = D = log (Ie/ It).   Equation 1
With such film, where visible light is the radiation, the ratio (Ie/It) is the film opacity; 
when x-rays are the radiation impinging on a material, this ratio is termed radiopacity: 
Radiopacity = Ie/ It.      Equation 2
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Taking the common logarithm of radiopacity yields the absorbance of the material: 
Absorbance = log (Radiopacity) = log ( Ie/ It)  Equation 3
Material absorbance for x-radiation is thus the equivalent of transmission film density. 
     The inverse of opaque is lucent, thus with x-radiation the inverse of radiopacity is 
radiolucence; this is also known as transmittance: 
Radiolucence = Transmittance = It /  Ie   Equation 4
     The above relationships are described in the chemical literature for determining the 
molecular structure by use of electronic spectroscopy (Atkins, 1986) and are usually 
referred to as either Beer’s Law or Beer-Lambert’s Law.  Beer’s Law (Adams, 2003) 
states: “for a parallel beam of monochromatic radiation passing through homogeneous 
solutions of equal pathlengths the absorbance is proportional to the concentration.”  
Lambert’s Law, according to Adams, states: “For a parallel beam of monochromatic 
radiation passing through homogeneous solutions of equal concentration the absorbance 
is proportional to the pathlength.”  
     Hubbell and Seltzer (2003) provide an exponential attenuation equation to determine 
radiopacity when a narrow beam of monoenergetic photons Ie penetrates a layer of 
material with a density ρ and a mass thickness x (where x = ρ t and t = component 
thickness), which emerges with intensity It, as follows: 
Radiopacity = (Ie/ It ) = exp [ (µ / ρ)( ρ t)].   Equation 5
Here µ is the linear absorption coefficient and µ / ρ is the mass attenuation coefficient; 
tables of µ / ρ for both elements and compounds are provided by Hubbell and Seltzer.  
The mass attenuation coefficient is experimentally determined but, as described by 
Hubbell and Seltzer, relies heavily on and correlates well with the theoretically 
determined total radiation cross section, including the atomic photoeffect cross section, 
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both coherent (Rayleigh) and incoherent (Compton) scattering cross sections, the cross 
sections for electron-positron production in the fields of the nucleus and of the atomic 
electrons, and the photonuclear cross section.  For compounds and mixtures, Hubbell 
and Seltzer assume that these coefficients may be found by simple addition according to 
the fraction by weight of each element, i, ci, which contribute to the compound or 
mixture: 
(µ / ρ)
compounds & mixtures
  = Σi  ci (µ / ρ)i .   Equation 6
Alloy density may be estimated using the following equation (Payling, 1997): 
.         Equation 7
     As can be seen from examination of Equation 2 and the mass attenuation coefficient 
tables provided by Hubbell and Selzer, if energy and t are invariant, the material 
radiopacity may be increased by increasing the overall elemental density.  Thus dense 
elements must be added to the UNS S31673 alloys in order to increase radiopacity. 
     The constraints on the radiopaque alloy to be developed are that, while it is accepted 
that the alloy will be a non-compliant alloy, the alloy will closely follow ASTM F 138-
00 and ASTM F139-00 in terms of composition, ideally increasing radiopacity of the 
modified UNS S31673 alloy at t = 0.127mm by nominally 30% at 80kV-100kV. 
2.5  Ensure no ferromagnetism 
     Stainless steels are complex multi-component alloys.  They can be air-quenched 
from approximately 600 °C to form a metastable gamma (face-centred cubic, or 
austenite) phase at room temperature.  The metastable gamma phase may include some 
ferrite phase, often referred to as delta ferrite (body-centred cubic), which is 
ferromagnetic at room temperature.  UNS S31673 alloys are required to be free of delta 
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ferrite when viewed at 100X magnification, in accordance with ASTM F138 and ASTM 
F139.  In addition, mechanically working the alloy (Dennis, Craig et al, 2003) may 
transform austenite into the martensite phase (body-centred tetragonal), which also is 
ferromagnetic.  A combination of a careful selection of alloying elements to strengthen 
the austenitic structure and repeated annealing treatments to reduce the stress level 
during such mechanical processing is required.  This latter will continually return the 
alloy to the austenitic state. 
     Many references exist on binary and ternary alloys.  These are helpful in developing 
an understanding of the complex nature of multi-component alloys such as austenitic 
stainless steel.  However, these alloys may react, as described in the preceding 
paragraph, to both thermal processing and mechanical treatments to change the alloy 
from what it was meant to be to one that is radically different from that which is desired. 
Because of the complex nature of multi-component austenitic stainless steel welds, 
Schaeffler (1949) devised an approach whereby certain of the alloying elements are 
utilised to display graphically whether the resulting alloy is predominantly austenitic, 
ferritic, or has the tendency to become martensitic (which may result from stresses due 
to the weld being constrained by the very structures it joins).  Using this approach, 
certain alloying elements are considered as being either nickel or nickel equivalents or 
chromium or chromium equivalents, as shown in Figure 4.  An alternate version was 
developed by de Long (1974), which includes the influence of nitrogen on the nickel 
equivalent.  These approaches also work well for stainless steel castings and have been 
widely adopted for such use.  In this study, only the Schaeffler diagram is used since 
little nitrogen is contained in these alloys; that diagram is thought more illustrative than 
the de Long, which has been incorporated in standards with a focus on ferrite numbers. 
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Figure 4 Schaeffler diagram (stainless steel welds) (Schaeffler, 1949) 
 
 
2.6 Freedom from inclusions or other deleterious phases 
     The essential requirement that UNS S31673 (or Composition D) alloys have been 
mandated to meet under British Standards Institute, International Standards 
Organisation, and ASTM International specifications has been freedom, in the fully 
annealed state, from such inclusions as would result if refinement through specialised 
melting practices such as vacuum arc remelting or electroslag melting were not utilised.  
These inclusions are sulphides, aluminates, silicates, and globular oxides.  For 
microcleanliness, the term used by ASTM International to describe absence of these 
inclusions, ASTM E45, Method A, is applied, which consists of a 100X optical 
examination of a polished surface, similar to the test that is applied to determine the 
presence of ferrite.  However, it has long been recognised that phases such as sigma, 
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Laves, and chi in stainless steels are deleterious for critical applications; the latest 
versions of the standards referred to above, ASTM F138-03 and ASTM F139-03, 
include determination of the contents of all these phases. 
     Although not a specification requirement at the time, the concern at the beginning of 
this study was upsetting the delicate compositional balance that minimised the potential 
for σ phase formation whilst in the process of attempting to increase alloy radiopacity.  
A parallel to the present application of austenitic stainless steels for coronary stents that 
addressed the deleterious effects of σ phase is in nickel-based superalloy development. 
Sigma phases tended to appear after long periods of operations at turbine operating 
temperatures and their presence reduced alloy ductility. Alloys susceptible to sigma 
phase precipitation were those that had high concentrations of alloying elements in the 
solid solution gamma phase (which is face-centred cubic). The alloy design 
methodology known as PHACOMP (for phase composition) emerged from studying 
that problem (Sims, 1988) and is used to predict the likelihood of sigma formation from 
a knowledge of the alloy composition.  A variant of PHACOMP, termed New 
PHACOMP, described by its originator, Morinaga (2001), has been applied to a number 
of superalloys, particularly those where nickel aluminides are utilised, and has also been 
applied to the ab initio design of ferritic steel alloys (Morinaga, 1994).  As a design 
tool, then, New PHACOMP may complement use of Schaeffler or de Long diagrams. 
     New PHACOMP parallels PHACOMP in one of its two approaches, assigning each 
transition element a value, in electron volts, which is an average of the components of 
the crystal field splitting parameter, the d-orbital t2g triplet and the d-orbital eg doublet 
(Pearson, 1972).  The Md numbers (i.e., d-orbital of element M) are summed to provide 
the compositional average of Md values in an alloy, Md(avg), defined as follows: 
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Md(avg) = ∑i  xi (Md)i.     Equation 8
The first term, xi, is the atomic fraction of component i of the alloy, and the second 
term, (Md)i, is the Md value for component i, while the summation of both is over all i. 
     Morinaga (1994, 2001) thus describes an approach that both parallels the original 
PHACOMP approach and offers the advantage that it is comprehensive and updated.  
Further, Morinaga was helpful in this research by determining the Md for elements that 
had not been previously determined or published, as will be described herein.   
      This approach also utilises a critical Md, described here as Md(crit), which can 
serve as an upper limit for the Md(avg) of a particular alloy and may indicate the 
presence of σ phase or some other deleterious phase.  Morinaga offers experiential 
evidence with other alloys using such an upper limit that has been tied to the presence of 
such phases but these are not universal in nature and thus serve primarily as alloying 
guidelines.  This relationship, which Morinaga (1985) argues is valid for the γ/γ+σ 
phase boundary, may be determined by applying the following experimentally-
determined formula: 
Md(crit) = [6.25 x 10-5 T] + 0.834    Equation 9
Here T is the temperature in kelvins.  Thus, if this formula holds for comparable alloys, 
when Md(avg) is equal to or greater than Md(crit), the σ phase should precipitate out. 
2.7 Mechanical properties 
     The tensile and yield strength and the ductility of the particular form applicable to 
ASTM F138 (bar and wire) or ASTM F139 (sheet and strip) are determined as proof of 
compliance.  As a design tool, the formula developed by Nordberg (1993) for use with 
stainless steels may be used to predict tensile and yield strength, as below: 
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Tensile Strength (MPa) =  470 + 600(N + 0.02) + 14Mo +1.5δ + 8d -0.5   Equation 10
      
Yield Strength  (MPa)  =  120 + 210√(N + 0.02) + 2Cr + 2Mn + 14Mo +10Cu 
 
+ δ(6.15 - 0.054δ ) + [7 + 35(N + 0.02)]d - 0.5    Equation 11
 
Here d is the grain size (in mm) and δ is delta ferrite content (in volume %).   
     Both ASTM F138-00 and ASTM F139-00 require a minimum ultimate tensile 
strength of 490 MPa and minimum yield strength of 190 MPa for annealed specimens, 
whether bar or sheet.  By adding back chromium, molybdenum, or nickel to an alloy 
that is diluted by addition of a radiopaque alloy, tensile and yield strength requirements 
should continue to be met.   
2.8 Corrosion 
 
     The addition of chromium to steel establishes a unique surface condition that gives 
rise to these steels being called ‘rust free’ or ‘stainless’ and additions of molybdenum 
enhance pitting resistance.  A pitting resistance equivalent number (PREN) may be 
determined by various formulae (Sedriks, 1996), which often includes nitrogen, but 
since nitrogen is allowed but only molybdenum is mandatory in the UNS S31673 alloys, 
the formula shown in Equation 7 is incorporated into the above specifications: 
PREN = [wt% Cr + 3.3 (wt% Mo)] = 26 (minimum).  Equation 12
An intergranular corrosion susceptibility test, ASTM A262 Practice E, is required of 
ASTM F138 and ASTM F139 alloys.  Biocompatibility testing of UNS S31673 alloys is 
not required since those alloys are used as control materials in ASTM F981, but any 
non-compliant alloy such as may result here would be required to be subjected to a 
biocompatibility testing regime to determine fitness for human use in a medical device. 
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2.9  Summary
     A design approach has been defined.  A single, high-atomic number element will be 
selected and added to a commercial variant of an implant grade austenitic stainless steel 
in order to preserve the desirable features of the base alloy and also minimise exception 
to the governing alloy specification as viewed by regulatory authorities.  Modelling of 
radiopacity, at a thickness comparable to that of coronary stents, is accomplished by use 
of Beer-Lambert’s Law, standardised coefficients of absorption, and single-beam x-
radiation that is expected to be a good approximation of actual experimental results.  
Modelling of the alloy to ascertain its propensity for ferromagnetic phases will be 
accomplished by use of Schaeffler diagrams, aided by standard binary phase diagrams.  
Modelling of the alloy to determine its propensity for sigma phase or other embrittling 
phases will be accomplished by use of a derivative of a superalloy modelling tool, 
‘PHACOMP’, which as ‘New PHACOMP’ has been in use for well over two decades, 
although it has not been previously applied to development of austenitic stainless steel.  
The average of the crystal field splitting parameters, the d-orbital triplet and doublet, 
and the experimentally-determined critical variant of that parameter, the latter based on 
success with determining the onset of sigma phase, are used.  Mechanical properties, 
namely tensile and yield strengths, will be modelled by use of the Nordberg equations.  
Finally, the onset of pitting resistance is identified both in the applicable specification 
for the base alloy and in the literature as a pitting resistance equivalent number, 
Equation 12, and is applied to ensure experiences gained with that are capitalised upon. 
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Chapter 3 
EXPERIMENTAL DESIGN AND RESULTS 
 
3.1 General
     The approach being used here was described in Craig et al (2003), wherein the UNS 
S31673 alloy is first reduced to a quaternary of required elements, in accordance with 
the two ASTM International documents describing either rod or bar stock (ASTM F138) 
or sheet or foil (ASTM F139).  Similar arguments would apply if utilising Composition 
D of either ISO 5832-1 or BS 7252-1.  The austenitic stainless steel has previously been 
described as comprised of approximately 2/3 iron and the remainder chromium and 
nickel; here a fourth required element is molybdenum.  Since chromium, nickel and 
molybdenum each have a fixed range (17-19wt% Cr; 13-15wt% Ni; 2.25-3.0wt% Mo) 
in the alloy, the iron content in the quaternary is considered as offering the greatest 
opportunity for change since it is described in all the above specifications as ‘balance’. 
Under the Unified National Standard definition of steel, the alloy remains so defined if 
the predominant element is iron.  This means iron could be reduced by half, to 1/3 the 
total, and a pentanary could be defined in which slightly less than 1/3 the total weight 
percent of the alloy is comprised of a single, high-atomic-number element.   
     While the approach described above applies for purposes of design and analysis, i.e., 
by reducing the specification to an alloy comprised of either a compliant quaternary or a 
non-compliant pentanary, the experimental approach entails use of a commercial, 
implant-grade alloy meeting UNS S31673 criteria and the ASTM F138-00 specification 
(Carpenter Technology’s BioDur® 316LS, in bar stock, unless otherwise noted).  This 
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alloy is re-melted with the high-atomic-number element added, along with additions of 
some or all required elements that would otherwise fall below the specification limits. 
3.2 Increase radiopacity 
     Before investigating the need for additional alloying elements to be added, it would 
be helpful to estimate the radiopacity of the UNS S31673 alloy. Considering only the 
four primary substitutional elements that are required of UNS S31673 alloys and 
utilising the midpoints of the required elemental weight percentages of those elements 
provides the following: chromium (18wt%), nickel (14wt%), molybdenum (2.5wt%), 
and iron (65.5wt%).  These four elements comprise a quaternary alloy; the radiopacity 
for this alloy is calculated by applying Equation 2 on a weighted-average basis to the 
elements of the quaternary; a thickness of 0.127mm (0.005 inches) is utilised, which is 
typical of the metal film or tubing wall thickness when fabricating coronary stents.  The 
radiopacity results are shown in Table 4 and Table 5 as equal to 1.07 and 1.04 
(dimensionless units), respectively, for 80 keV and 100keV (energies well within the 
spectrum typically used during stent deployment for which data are readily available).  
Table 6 shows the radiopacities of each element of the quaternary alloy.  Achieving a 
30% increase in radiopacity at each energy level for the alloy would result in 
radiopacity units of 1.39 and 1.34 at 80keV and 100keV, respectively, as shown in 
Table 4 and Table 5. 
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Table 4 – Quaternary alloy (Q) showing resultant radiopacity at 80keV (density, ρ, and 
mass attenuation coefficient, µ/ρ, from tables provided by Hubbell and Selzer, 1997) 
 
Z Element Density, ρ µ/ρ 80keV thickness wt% R (alloy) 
  g/cm3 µ = cm-1 cm  @80keV 
24 Cr 7.18 0.49 0.0127 18 = 
26 Fe 7.87 0.6 0.0127 65.5 1.07 
28 Ni 8.9 0.73 0.0127 14 To increase: 
42 Mo 10.22 1.96 0.0127 2.5 130% R(Q) 
      = 
      1.39 
 
 
Table 5 – Quaternary alloy (Q) showing resultant radiopacity at 100keV (density, ρ, and 
mass attenuation coefficient, µ/ ρ, from tables provided by Hubbell and Selzer, 1997) 
 
Z Element Density, ρ µ/ρ 100keV thickness wt% R (alloy) 
  g/cm3 µ = cm-1 cm  @100keV 
24 Cr 7.18 0.32 0.0127 18 = 
26 Fe 7.87 0.37 0.0127 65.5 1.04 
28 Ni 8.9 0.44 0.0127 14 To increase: 
42 Mo 10.22 1.1 0.0127 2.5 130% R(Q) 
      = 
      1.35 
 
 
Table 6 – Calculated radiopacities for primary elements of UNS S31673 (t = 0.127mm) 
 
 Cr Fe Ni Mo 
R80 keV 1.046 1.061 1.086 1.290 
R100 keV 1.029 1.038 1.051 1.153 
 
 
     Since the physical constants of the elements are fixed, as for these purposes is the 
thickness, it is impossible for this quaternary alloy to achieve 130% of its radiopacity.  
This increase can only be accomplished by removing some portion of one or more 
elements and replacing that portion with a more radiopaque element.  Ideally, this 
would be achieved within the constraints of the governing specifications, but if not, the 
element should complement existing elements to achieve a stable, biocompatible alloy; 
the list of acceptable elements does not include high-atomic-number elements. 
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However, as noted above, since the compositions comprised of chromium, nickel, and 
molybdenum are essentially fixed, iron, shown in the several specifications as ‘balance’, 
is the only element that may be changed without going outside the bounds of those 
specifications.  Since iron must be the predominant element for the alloy to be described 
as a stainless steel when the Unified National Standard designation is applied, as with 
the ASTM International specifications, iron could be removed to a level of 33wt% and a 
new element could be added in an amount up to 32.5wt%.  While such an addition, one 
not from the palate of optional elements in the listed specifications, brings the alloy into 
non-compliance, the concept implemented is to remain compliant on all but this matter. 
     Selecting a fifth element and adding that to those comprising the quaternary alloy 
results in a pentanary alloy.  Selecting only elements sufficiently radiopaque to increase 
overall radiopacity to approximately 130% of that of the quaternary at each energy level 
and well within conservative metallurgical practice for stainless steel, i.e., use of non-
allotropic d-block elements exhibiting close packed structures, leads to selection of the 
seven elements beginning with Z = 73 (tantalum) through Z = 79 (gold).  The 
radiopacities of these elements are shown in Table 7; elemental thickness is 0.127mm. 
Table 7 – Calculated radiopacities for radiopaque elements for pentanary alloy  
(t = 0.127mm) 
 
 Ta W Re Os Ir Pt Au 
R80 keV 4.98 6.78 8.62 10.77 11.52 10.79 8.88 
R100 keV 2.48 2.97 3.41 3.85 3.99 3.89 3.55 
 
 
     The radiopacities for the pentanary are calculated with each of these elements 
replacing, in turn, the maximum amount of iron; the results are as shown in Table 8 and 
in Table 9.  All seven elements shown in Table 8 (radiopacities at 80keV) meet the 
criteria of 130% of that of the quaternary, while none of the elements in Table 9 do.   
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Table 8 – Pentanary alloy showing resultant radiopacity at 80keV (density, ρ, and mass 
attenuation coefficient, µ/ ρ, are from tables provided by Hubbell and Selzer, 1997) 
 
Z Element Density, ρ µ/ρ 80keV thickness wt% R (alloy)  
  g/cm3 µ = cm-1 cm  @ 80keV 
24 Cr 7.18 0.49 0.0127 18  
26 Fe 7.87 0.6 0.0127 33  
28 Ni 8.9 0.73 0.0127 14 (130%Q=1.39)
42 Mo 10.22 1.96 0.0127 2.5  
X (choose) (choose) (choose) 0.0127 32.5  
X = 
73 Ta 16.65 7.59 0.0127 32.5 1.42>130%Q 
X = 
74 W 19.3 7.81 0.0127 32.5 1.45>130%Q 
X = 
75 Re 21.02 8.07 0.0127 32.5 1.47>130%Q 
X = 
76 Os 22.57 8.29 0.0127 32.5 1.49>130%Q 
X = 
77 Ir 22.42 8.59 0.0127 32.5 1.51>130%Q 
X = 
78 Pt 21.45 8.73 0.0127 32.5 1.51>130%Q 
X = 
79 Au 19.32 8.9 0.0127 32.5 1.51>130%Q 
 
 
Table 9 – Pentanary alloy showing resultant radiopacity at 100keV (density, ρ, and mass 
attenuation coefficient, µ/ ρ, are from tables provided by Hubbell and Selzer, 1997) 
 
Z Element Density, ρ µ/ρ 100keV thickness wt% R(alloy) 
  g/cm3 µ = cm-1 cm  @100keV 
24 Cr 7.18 0.32 0.0127 18  
26 Fe 7.87 0.37 0.0127 33  
28 Ni 8.9 0.44 0.0127 14 (130%Q=1.35)
42 Mo 10.22 1.1 0.0127 2.5  
X  (choose) (choose) (choose) 0.0127 32.5  
X = 
73 Ta 16.65 4.3 0.0127 32.5 1.22<130%Q 
X = 
74 W 19.3 4.44 0.0127 32.5 1.24<130%Q 
X = 
75 Re 21.02 4.59 0.0127 32.5 1.25<130%Q 
X = 
76 Os 22.57 4.7 0.0127 32.5 1.26<130%Q 
X = 
77 Ir 22.42 4.86 0.0127 32.5 1.27<130%Q 
X = 
78 Pt 21.45 4.99 0.0127 32.5 1.27<130%Q 
X = 
79 Au 19.32 5.16 0.0127 32.5 1.27<130%Q 
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3.3 Maintain precipitate free austenitic structure 
     Maintaining the gamma (γ) or face-centred cubic structure that is known as austenite 
in steel is a key issue in choosing an alloying element to replace part of the iron from 
the alloy.  Here part of the iron from the quaternary is being replaced to increase 
radiopacity in the resulting pentanary.  The radiopaque elements in Table 7 are defined 
as follows: tantalum and tungsten are body-centred cubic; rhenium and osmium are 
hexagonal close-packed; and iridium, platinum, and gold are face-centred cubic. 
     Binary phase diagrams for iron-tantalum, iron-tungsten, and gold-iron are shown in 
Figure 5, Figure 6, and Figure 7, respectively.  It is seen that the γ loop containing the 
austenite in each of these is not sufficiently large to sustain approximately 32.5wt% of 
the radiopaque elements.  In addition, the binary for iron-tantalum indicates the 
presence of both an epsilon (Structurbericht C14) and a mu (Structurbericht D85) phase 
that would be incompatible with the desired austenitic phase in the pentanary alloy. 
 
Figure 5 Iron-Tantalum Phase Diagram (Okamoto, 1996) 
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Figure 6 Iron-Tungsten Phase Diagram (Naidu et al, 1993) 
 
 
 
Figure 7 Gold-Iron Phase Diagram (Okamoto et al, 1990) 
 
 
     The binary phase diagram for iron-osmium is in Figure 8; the quite large γ field is 
typical of both iron-osmium and iron-rhenium and is more than sufficient to sustain 
32.5wt% of the elements.  The remaining two elements are both face centred cubic and 
have open γ fields, as shown in Figure 9 and Figure 10 for iron-iridium and iron-
platinum, respectively.   
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Figure 8 Iron-Osmium Phase Diagram (Swartzendruber and Sundman, 1983) 
 
Figure 9 Iron-Iridium Phase Diagram (Swartzendruber, 1990) 
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Figure 10 Iron-Platinum Phase Diagram (Okamoto, 1990) 
 
     There is the possibility of an epsilon (hexagonally close packed) phase in a binary of 
iron-iridium with 32.5wt% iridium.  No such phase is apparent with iron-platinum and 
only a somewhat poorly-defined Fe3Pt phase (Structurbericht L12) exists that appears to 
begin at approximately 38wt% platinum, well above the 32.5wt% platinum required.  
Both osmium and rhenium are hexagonally close packed but, as noted above, have a γ 
field sufficient to accommodate the required increase in density in a binary alloy. 
     Investigating further the possibility of using platinum as the radiopaque element, it is 
quite compatible with nickel, Figure 11, as would be expected since both are face 
centred cubic Group VIIIA elements and in the same column on the periodic table. 
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Figure 11 Nickel-Platinum phase diagram (Nash, 1990) 
 
However, face centred cubic platinum is not quite as compatible with body centred 
cubic chromium, as shown in Figure 12; an intermetallic compound exists in the binary 
but it is at levels of platinum approximately 10wt% higher than anticipated for use here. 
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Figure 12 Chromium-Platinum  phase diagram (Venkatraman and Neumann, 1990) 
 
   The Schaeffler diagram, Figure 4, provides a nickel equivalent for manganese of  
0.5 but does not address platinum or iridium.  Moema and Paton (2002) determined the 
nickel equivalent for these elements to be approximately 0.5 for platinum and 0.4 for 
iridium, thus these can be included on a variant of the Schaeffler diagram.  Schaeffler 
provides a chromium equivalent for molybdenum (1.0) but does not for tungsten, which 
is also a body-centred cubic Group VIA element.  On the premise that body centred 
cubic tungsten also may have the same equivalency to chromium as molybdenum, also 
Group VIA, it is assigned such an equivalency (1.0) here.  Based on a similar 
parallelism with the platinum-iridium equivalency determinations (where platinum was 
determined to have a nickel equivalency of 0.5 and iridium 0.4), tantalum, in Group 
VA, is arbitrarily assigned an equivalency (0.8) since, like iridium is to platinum, it is in 
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an adjacent column to the left and has a smaller atomic radius.  In this case, the tantalum 
parallelism is to that of chromium-molybdenum-tungsten, which has unity equivalence 
with chromium.  The resulting Schaeffler diagram, Figure 13, shows the quaternary 
alloy lies just outside the austenite ‘V’ at 14wt% nickel and 18wt% chromium with 
perhaps 1-2% ferrite. Figure 13 shows the pentanary alloys containing 32.5wt% 
tantalum, tungsten, iridium, and platinum; rhenium and osmium are not shown since 
they are both hexagonal close packed and have no apparent equivalency to either nickel 
or chromium.   
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Figure 13 – Schaeffler diagram showing platinum and iridium as nickel equivalents and 
tungsten and tantalum as chromium equivalents in pentanary, versus quaternary 
 
The tantalum and tungsten pentanary alloys are predominantly ferritic, as would be 
expected on adding such large amounts of body centred cubic elements to a face centred 
cubic structure such as the quaternary; this would appear to be true whether or not the 
assumptions about their chromium equivalency described above holds.  Similarly, the 
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iridium and platinum pentanary alloys are clearly austenitic, again as expected on 
adding face centred cubic elements with broad solubility to the austenitic quaternary. 
     In determining the two New PHACOMP parameters, Md(avg) and Md(crit), 
described in §2.6, Equation 8 and Equation 9, the Md numbers provided in Morinaga 
(2001a; 2001b) are required, Table 10.  Note Md numbers are only provided for metals. 
 
Table 10 New PHACOMP Md numbers (Morinaga, 2001a; 2001b) 
Element 
Z  
Cr 
24 
Mn 
25 
Fe 
26 
Co 
27 
Ni 
28 
Cu 
29 
Mo 
42 
Md (eV) 1.142 0.957 0.858 0.777 0.717 0.615 1.550 
Element 
Z 
Ta 
73 
W 
74 
Re 
75 
Os 
76 
Ir 
77 
Pt 
78 
Au 
79 
Md (eV) 2.224 1.655 1.267 1.063 0.907 0.764 0.627 
 
The Md(crit) value utilised in the development of a ferritic stainless steel, 1100 °C, is 
used here (Morinaga et al, 1994); the concern there, as here, is with the sigma phase that 
is proscribed in the latest variant of standards ASTM F138-03 and ASTM F139-03.  
Figure 14 is the binary phase diagram for iron-chromium and its intermetallic σ phase; 
the iron-chromium γ phase that is the underlying basis of stainless steel is also shown. 
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Figure 14 Iron-Chromium binary phase diagram (Massalski, 1990) 
 
     Using the pentanary alloys shown as Table 11, the New PHACOMP results are 
shown for the body centred cubic enhanced alloys (tantalum and tungsten) in Table 12, 
the hexagonally close packed enhanced alloys (rhenium and osmium), Table 13, and the 
face centred cubic alloys (iridium, platinum, and gold), Table 14. 
Table 11 Pentanary alloys using minimised quaternary plus element “X” 
Z Element Density, ρ Md(eV) wt% 
24 Cr 7.18 1.142 18 
26 Fe 7.87 0.858 33 
28 Ni 8.9 0.717 14 
42 Mo 10.22 1.550 2.5 
X = 73 Ta 16.65 2.224 32.5 
X = 74 W 19.3 1.655 32.5 
X = 75 Re 21.02 1.267 32.5 
X = 76 Os 22.57 1.067 32.5 
X = 77 Ir 22.42 0.907 32.5 
X = 78 Pt 21.45 0.764 32.5 
X = 79 Au 19.32 0.627 32.5 
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Table 12 Body centred cubic elements tantalum and tungsten used to enhance 
radiopacity of quaternary alloy shown in Table 4 and Table 5 
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Table 13 Hexagonal close packed elements rhenium and osmium used to enhance 
radiopacity of quaternary alloy shown in Table 4 and Table 5 
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Table 14 Face centred cubic elements iridium, platinum, and gold used to enhance 
radiopacity of quaternary alloy shown in Table 4 and Table 5 
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3.4 Strength predictions
     Applying the Nordberg equations for tensile and yield strength described in §2.7, 
Equation 10 (tensile) and Equation 11 (yield), to an alloy meeting ASTM F139 
specifications in terms of ferrite content (0wt%) and minimum grain size (0.045mm, or 
ASTM E112 grain size 5), the result is the same for all pentanary alloys if no 
consideration is made of the influence of the high-atomic-number alloying elements, 
i.e., 555MPa tensile strength and 247MPa yield strength.  In ASTM F139, the minimum 
acceptable tensile and yield strength for annealed alloys in either sheet or strip form is 
shown as 490MPa and 190MPa, respectively.   
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3.5 Corrosion
     Two criteria are applied in ASTM F139-00.  Susceptibility to intergranular corrosion 
is determined by ASTM A262, Practice E, which requires samples to be embedded in 
copper granules and exposed for 24 hours in equal parts of a boiling solution of 
hydrated copper sulphate  and concentrated sulphuric acid.  After exposure, the samples 
are bent through 180 degrees over a mandrel with a diameter equal to the thickness of 
the samples, then examined at 20X magnification for cracks indicating sensitisation.  
For pitting resistance, Equation 12 is applied, thus only chromium and molybdenum 
contents are considered.  For these alloys, with 18wt% chromium and 2.5wt% 
molybdenum: 18 + 3.3 (2.5) = 26.25, thus the minimum pitting resistance number of 26, 
as stipulated in ASTM F138 and ASTM F139, is achieved with all the pentanary alloys. 
3.6 Results
• Seven high-atomic-number elements were considered for the pentanary element 
• All proposed pentanary elements exhibit insufficient radiopacity at 100keV 
• Tantalum, tungsten, rhenium, osmium, and iridium exceed the Md(crit) value 
• Gold has insufficient solubility in iron to sustain the required level (32.5wt%) 
• Platinum meets or exceeds all criteria (except 100 keV radiopacity increase) and 
is chosen as the alloying element; platinum content is below the level shown in 
Figure 10 where a secondary phase, Fe3Pt, may occur in a binary alloy 
• Platinum content is well below the level shown in Figure 12 where an 
intermetallic compound, Cr3Pt, may occur in a binary alloy 
• Strength is adequate; pitting corrosion is acceptable; corrosion testing required 
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Chapter 4 
EXPERIMENTAL METHODS AND RESULTS 
 
4.1 Introduction
     In §3.6, only platinum was identified as meeting all the requirements for use as a 
single, high-atomic-number substitutional element to maximise the radiopacity of the 
pentanary when iron is at its minima, as well as meeting several other requirements.  
Such substitution would potentially increase radiopacity of the pentanary by up to 30%. 
     As inferred in Chapter 3, a two-pronged experimental approach was devised.  The 
first condition of the research was that a commercial alloy meeting specifications 
representative of international usage for stainless steel coronary stents would be chosen 
and that this commercial alloy would be remelted along with a single ‘radiopaque’ 
element not previously specified in those, i.e., an element that is not presently allowed.  
In the second part of the approach, the departure from specification requirements was 
minimised by allowing the mandatory ‘balance’ element in the alloy, iron, to decrease, 
while augmenting the remaining mandatory elements that are diminished upon addition 
of platinum.  The latter condition was possible because iron could be substantially 
reduced within the constraints of the specification, i.e., under the Unified National 
Standard adopted by ASTM International and in wide use elsewhere, as long as iron 
remains the principal element in the resulting alloy, the alloy is considered steel. 
     The experimental work described below is meant to address the core problem of 
increasing radiopacity while maintaining substantial adherence to the specification 
context that represents the technological and historical basis for using austenitic 
stainless steel as implants, especially fabrication of balloon-expandable coronary stents.   
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Adherence to internationally-accepted standards for austenitic stainless steel used in 
fabricating balloon-expandable coronary stents is based on ensuring: (a) no 
ferromagnetism; (b) freedom from embrittling phases; (c) adequate mechanical 
properties; and (d) adequate corrosion properties.  
     The bulk of the research has been carried out using small ingots, typically 100-350g, 
made in a button furnace.  Due to the expense of the raw materials, especially platinum, 
and the number of ingots required, producing small ingots was the preferred approach.  
These experiments are described in three stages: (a) a proof-of-concept stage, adding up 
to 5wt% platinum to a commercial UNS S31673 alloy, (b) a second stage meant to more 
thoroughly analyse metallurgical and radiological properties of low-radiopacity alloys, 
adding up to 10wt% platinum to a UNS S31673 alloy, and (c) a third stage focussed on 
determining if overall radiopacity goals can be met within the resulting microstructures, 
adding up to 35wt% platinum to a commercial UNS S31673 alloy. 
     A pilot production effort was also undertaken, with ingot sizes on the order of 50kg, 
applying manufacturing processes comparable to commercial practice, i.e., vacuum 
induction and vacuum arc remelt furnaces.  As with the 0-10wt% platinum button 
furnace ingots, the focus was on producing ingots that lead to products that conform to 
ASTM F139, with the exception of added platinum, which are comparable in quality to 
commercial UNS S31673 alloys.  These ingots could either be made directly into 
seamless tubing or be rolled into foil that could in turn be made into welded tubing.  
While this research did not entail making either type of tubing or fabricating stents from 
those, the rolling processes are ancillary to this research since ASTM F139, which 
describes wrought products, was the basis of the final testing of these products.  These 
pilot manufacturing efforts culminate in production and comprehensive analysis of 
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several 5-6wt% platinum alloys and one 30wt% platinum alloy, here described as 
‘conforming’ alloys, to the full spectrum of requirements outlined in ASTM F139-00. 
     Tubing made from early versions of products of the pilot production effort, a 
conforming 5wt% platinum alloy and a non-conforming 30wt% platinum alloy, the 
latter alloy one in which nickel was substantially below the minimum required by 
ASTM F139, were analysed by transmission electron microscopy and by energy 
dispersive spectroscopy.  No tubing was made from the conforming 30wt% platinum 
alloy, a small 300g ingot derived from a larger non-conforming 30wt% platinum alloy.   
4.2 Conforming, proof-of-concept button melts (1-5wt% platinum) 
4.2.1 Introduction and approach 
     The initial efforts to make a platinum-containing alloy by melting a UNS S31673 
alloy, Carpenter Technology’s BioDur 316LS, was meant to show that platinum would 
go into solution with the commercial alloy as a fully austenitic stainless steel and that no 
unexpected precipitates would form.  The New PHACOMP method, binary diagrams 
and Schaeffler diagrams, and the Nordberg equations were used as modelling tools.   
4.2.2 Experiment 
     Button furnace samples were made by adding nominally 1wt%, 2wt%, 3wt%, 4wt%, 
and 5wt% platinum to BioDur® 316LS (Table 15).   
Table 15 Preliminary alloys containing platinum plus base UNS S31673 alloy 
(BioDur® 316LS); (all results in wt%) 
 
Target Cr Fe Ni Mo Pt 
BioDur® 316LS 17.50 62.29 14.71 2.85   
1wt% Pt 17.27 61.76 14.54 2.83 1.06 
2wt% Pt 17.17 61.09 14.28 2.81 2.09 
3wt% Pt 17.02 60.45 14.14 2.82 2.97 
4wt% Pt 16.92 59.86 13.94 2.80 3.96 
5wt% Pt 16.74 59.36 13.75 2.75 4.94 
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     BioDur® 316LS rod conforming to ASTM F138-00 was used as the base material.  
One ingot was remelted without additions of high-atomic-number elements so it could 
be comparably processed with those samples containing varying amounts of platinum. 
     The ingots, each approximately 100 grams, were prepared in a vacuum arc button 
furnace, capable of up to approximately 500 grams, with a non-consumable thoriated 
tungsten anode and a water-cooled copper hearth, Figure 15.  The button furnace was 
loaded with the raw materials, evacuated, and then backfilled to approximately 0.033 
MPa with argon. 
 
Figure 15 Vacuum arc button furnace used to cast small austenitic stainless steel ingots 
(United States Department of Energy, Albany Research Centre, Albany, Oregon) 
 
     The resulting ingots were milled to produce parallel surfaces in the thickness 
direction and corners were rounded in preparation for rolling.  The samples were placed 
in a furnace at room temperature and slowly brought to 875°C (2.5 hours), then heated 
rapidly to a rolling temperature of 1150°C to 1250°C (3.0 hours).  The samples were at 
approximately 1200°C at the commencement of rolling in a two-high mill (Figure 16).  
From an initial thickness of approximately 8-10mm, the samples were rolled to 3.0mm.  
The mill settings were reduced 15% for each pass; samples were given a five-minute 
 58
reheat between passes.  After the final rolling mill pass, all samples were flattened on a 
forge press, Figure 17, annealed at 1000°C for fifteen minutes, and water quenched.  
 
 
 
Figure 16 Two-high rolling mill used to hot-roll austenitic stainless steel plate 
(United States Department of Energy, Albany Research Centre, Albany, Oregon) 
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Figure 17 Forge used to upset cast austenitic stainless steel ingots  
(United States Department of Energy, Albany Research Center, Albany, Oregon) 
 
 
4.2.3 Results 
4.2.3.1 X-ray diffraction 
     X-ray diffraction measurements using an automated Philips x-ray diffractometer 
were made on all samples, which were final polished with diamond paste.  A copper-
anode x-ray tube was used, operated at 45kV and 35mA, using a variable divergence 
slit, vertical goniometer, diffracted beam monochromator and scintillation counter.  
Phase content determinations were made from x-ray diffraction step scans collected 
over a two-theta angular range of 5-80 degrees using a 0.02 degree step size and a 
counting time of 2 seconds per step.  Phase identification was made using x-ray 
diffraction patterns contained in the International Centre for Diffraction Data® Powder 
Diffraction File (ICDD, 2000).  The resulting chemical composition of the base alloy 
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and the five alloys containing platinum, shown in Table 15, are included in Table 16, 
where they are combined with x-ray diffraction results. 
Table 16 Preliminary alloys containing platinum plus base UNS S31673 alloy (wt%) 
 
Target Cr Fe Ni Mo Pt XRD 
BioDur® 316LS 17.50 62.29 14.71 2.85   fcc only 
1wt% Pt 17.27 61.76 14.54 2.83 1.06 fcc only 
2wt% Pt 17.17 61.09 14.28 2.81 2.09 fcc only 
3wt% Pt 17.02 60.45 14.14 2.82 2.97 fcc only 
4wt% Pt 16.92 59.86 13.94 2.80 3.96 fcc only 
5wt% Pt 16.74 59.36 13.75 2.75 4.94 fcc only 
 
     As shown in Table 16, the primary phase in each alloy remained face centred cubic 
(fcc).  No additional phases were found in either the base UNS S31673 alloy, BioDur® 
316LS, or in any of the five alloys having platinum added to the base alloy.  
4.2.3.2 Schaeffler diagram 
     Using the chemical compositions shown in Table 15 and Table 16, Schaeffler 
diagrams were constructed for the alloys.  These diagrams are shown in Figure 18.   
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Figure 18 Schaeffler diagram for preliminary alloys containing platinum 
 
     The Schaeffler diagram for the face centred cubic alloying element platinum, Figure 
18, based on approximately two parts platinum being equivalent to one part nickel, 
indicates the platinum-containing alloys become more strongly austenitic as platinum is 
increased from the base UNS S31673.   
4.2.3.3 New PHACOMP 
     Using the chemical compositions shown in Table 15 and Table 16, a New 
PHACOMP table was constructed for the alloys.  This table is shown in Table 17. 
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Table 17 New PHACOMP results for preliminary alloys containing platinum 
(Md critical set at 0.920eV, 1100°C) 
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     In Table 17, the Md(critical) was set at 0.920eV and does not interact with the alloys 
from base through 5wt% platinum.   
4.2.3.4 Mechanical properties 
     Both calculated and experimental tensile and yield strength for the base and 
platinum-containing alloys described in Table 15 are shown in Table 18.  The Nordberg 
equations, Equation 10 (tensile) and Equation 11 (yield), were used to obtain calculated 
results; carbon was assumed to be 0.016wt%, grain size 0.0449mm, and ferrite nought.  
Experimental data were obtained using a standard servohydraulic tensile test system 
(Instron) with a 2500kg load cell, a one-inch (25.4mm) extensometer, and 0.5mm/min 
crosshead speed.  Temperature was 21°C; humidity 0%.  Nominal sample width was 
0.250in (6.35mm) and nominal thickness 0.100in (2.54mm).   
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Table 18 Strength calculations for preliminary 0-5wt% platinum in UNS S31673 
(C = 0.016wt%; ASTM grain size 6 = 0.0449mm; ferrite = 0wt%) 
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     At 409MPa, the tensile strength of the base sample was substantially below the 
minimum (490Mpa) required by ASTM F139-00; yield strength (188Mpa) was almost 
equal to the minimum required (190Mpa).  However, the calculated and experimental 
tensile and yield data for all five samples containing platinum corresponded well, with 
the experimental data slightly greater than found by the Nordberg equations, indicating 
the addition of platinum increases both tensile and yield strength.  Table 19 repeats the 
experimental tensile and yield strength data and provides elongation and hardness data.  
Increase in strength with platinum content is further indicated by the hardness increases. 
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Table 19 Mechanical and physical property data for preliminary 0-5wt% platinum 
 
Sample ASTM 
F139-00 
Base 
31673
1wt% Pt 2wt% Pt 3wt% Pt 4wt%Pt 5wt% Pt 
 
UTS 
MPa 
490 409 571 574 580 587 590 
YS 
MPa 
190 188 292 297 305 305 307 
Elong-
ation % 
40 min. 62 62 61 60 63 63 
Hardness 
Rockwell 
B 
95 max. 70.9 76.3 77.8 77.7 77.4 79.2 
 
 
4.2.3.5 Corrosion 
     The pitting resistance equivalence number calculations, Equation 12, for the alloys in 
Table 15 are shown in Table 20.  Note all but the 5wt% platinum alloy are acceptable. 
 
Table 20 Pitting resistance equivalence number calculation for 0-5wt% platinum alloys 
 
Target 
 
Equation 12 
 
Result 
BioDur® 316LS 
Σ (17.50wt% Cr + 3.3 
(2.85wt% Mo) 
PREN = 26.9 (=/> 26 req. by 
ASTM F139) 
1wt% Pt 
Σ (17.27wt% Cr + 3.3 
(2.83wt% Mo) 
PREN = 26.6 (=/> 26 req. by 
ASTM F139) 
2wt% Pt 
Σ (17.17wt% Cr + 3.3 
(2.81wt% Mo) 
PREN = 26.4 (=/> 26 req. by 
ASTM F139) 
3wt% Pt 
Σ (17.02wt% Cr + 3.3 
(2.82wt% Mo) 
PREN = 26.3 (=/> 26 req. by 
ASTM F139) 
4wt% Pt 
Σ (16.92wt% Cr + 3.3 
(2.80wt% Mo) 
PREN = 26.2 (=/> 26 req. by 
ASTM F139) 
5wt% Pt 
Σ (16.74wt% Cr + 3.3 
(2.75wt% Mo) 
PREN = 25.8 (< 26 req. by 
ASTM F139) 
 
4.2.4 Summary 
     The element platinum was used to demonstrate that the concepts derived from the 
solubility approach are predictable utilising a combination of binary phase diagrams, 
Schaeffler diagrams, and New PHACOMP.  In particular, when x-ray diffraction results 
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from 1-5wt% of each alloy are compared to New PHACOMP Md(avg) results for each 
of the alloys, the Md(crit) set at 1100°C where sigma phase in these alloys would be 
represented was well above the maximum Md(avg) for any of the alloys.  This appears 
to support use of Md(avg) and Md(crit) as valid indicators and thus the utility of New 
PHACOMP as a predictive method for platinum-containing austenitic stainless steels. 
     For the platinum-containing alloys, strength measurements for the five samples were 
in relatively close agreement with the predicted values from the Nordberg equations, 
discounting the base alloy, which was anomalous.  Average calculated yield strength 
values lagged the average experimental values by approximately 13.5%.  Average 
calculated ultimate tensile strength values lagged the average experimental values by 
approximately 1.5%.   
     Discounting the base alloy, experimental data for the 5wt% platinum-containing 
alloy was found to be approximately 5% greater than the 1wt% platinum alloy for yield 
strength and approximately 3% greater for ultimate tensile strength.  This indicates 
strength increases with platinum content.  As noted above, the hardness values shown in 
Table 19 confirm this trend, increasing approximately 1% from 1-5wt% platinum. 
     The pitting resistance equivalent number for the 5wt% platinum alloy was slightly 
less than required by ASTM F139-00, indicating a need to add chromium and 
molybdenum to the alloy during the initial melting of the BioDur® 316LS with the 
platinum so this requirement will be met by all alloys processed in this manner. 
4.3 Conforming, low-radiopacity button melts (0-10wt% platinum)      
4.3.1 Introduction and approach
     Preparing UNS S31673 alloys from elements rather than adding platinum to a 
commercial UNS S31673 alloy was undertaken in this second phase, also using a button 
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furnace, similar to that described in §4.2.2.  The objectives were to increase radiopacity 
to the point it could be measured with some certainty and to complete a more thorough 
analysis of the resulting alloys.  This phase has been described in Craig et al (2003). 
4.3.2 Experiment 
     Five ingots, four containing added platinum, were prepared in a vacuum button 
furnace, backfilled at approximately 0.33MPa argon, using a triple-melt procedure 
wherein the cooled alloy is turned over and remelted so as to increase mixing.  The 
ingots were cleaned, forged, cold-rolled to two thicknesses (1.27mm; 0.127mm), and 
annealed at 1050°C, followed by a water quench.  A commercial UNS S31673 alloy, 
Sandvik Bioline® 316LVM, was used as a reference alloy; this alloy was remelted in 
the button furnace to simulate conditions seen by the other alloys.  Table 21 provides 
the full chemical composition of these five alloys, which comply compositionally with 
ASTM F139-00, with the exception of having added platinum. 
 
Table 21 Chemical composition of UNS S31673 and platinum-containing alloys,  
0 - 10wt% (shown in weight percent)(Craig et al, 2003) 
 
Element ASTM F139-00 0wt% Pt
 
1wt% Pt 3wt% Pt 6wt% Pt 10wt% Pt 
Pt Not allowed - 1.21 3.04 6.46 10.14 
Cr 17-19 19.70 18.20 18.30 18.40 19.20 
Ni 13-15 13.57 13.5 13.71 13.52 13.87 
Mo 2.25-3.0 2.62 2.55 2.55 3.07 3.01 
Mn 2.0 max. 1.38 1.32 1.50 1.55 1.56 
Cu 0.5 max. 0.055 <0.005 <0.005 <0.005 <0.005 
C 0.030 max. 0.018 0.014 0.013 0.016 0.018 
N 0.10 max. 0.028 0.034 0.099 0.037 0.051 
Si 0.75 max. 0.25 0.08 0.08 0.08 0.08 
P 0.025 max. <0.001 0.004 0.001 0.001 0.004 
S 0.010 max. 0.002 0.003 0.002 0.002 0.004 
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4.3.3 Results 
4.3.3.1 X-ray diffraction 
     X-ray diffraction was accomplished similar to that described in §4.2.3.1.  Only 
austenite was found; any ferrite may have been masked by the background radiation.  
These results are shown in Table 22. 
 
Table 22 UNS S31673 and platinum-containing alloys, 0 - 10wt% (Craig et al, 2003) 
 
Target Cr Fe Ni Mo Pt XRD 
0wt% Pt 19.70 62.38 13.57 2.62 - fcc only 
1wt% Pt 18.20 63.08 13.50 2.55 1.21 fcc only 
3wt% Pt 18.30 60.71 13.71 2.55 3.04 fcc only 
6wt% Pt 18.40 56.86 13.52 3.07 6.46 fcc only 
10wt% Pt 19.20 52.06 13.87 3.01 10.14 fcc only 
 
 
4.3.3.2 Schaeffler diagram and ferrite measurements 
       The austenitic nature of the five samples described in Table 21 is shown in the 
Schaeffler diagram, Figure 19.  Only the base alloy is projected to contain ferrite since 
the austenitising effect of the platinum drives the alloy further into the austenitic range. 
     Ferrite content was measured in the as-cast, annealed, and cold-rolled conditions for 
the five samples described in Table 21 using a Fischer Feritscope MP30.  This 
instrument measures the degree of magnetism in the alloy, converting to ferrite content.       
For the 0wt% platinum alloy, using the Feritscope MP 30, approximately 3.9% ferrite 
was found in the as-cast condition, compared with approximately 4% ferrite shown on 
the Schaeffler diagram. For the same alloy, approximately 0.7% ferrite was found in the 
cold-rolled condition.  No ferrite was detected for any alloy in the annealed condition.   
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Figure 19 Schaeffler diagram for UNS S31673 and platinum-containing alloys,  
0 - 10wt% (Craig et al, 2003) 
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4.3.3.3 New PHACOMP and microscopic analysis 
     The New PHACOMP results for the 0-10wt% platinum alloys described in Table 21 
are shown in Table 22; the Md(crit) is set at 1100°C, some 50°C above the annealing 
temperature.  No sigma-type precipitates are predicted; the Md(avg) of all alloys is well 
below Md(crit) and becomes more stable with the addition of platinum, as expected 
since the austenitising effect of platinum is reflected in a lowering of the Md(avg). 
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Table 23 New PHACOMP results for UNS S31673 and platinum-containing alloys,  
0 - 10wt% (Md critical set at 0.920eV, 1100°C) 
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     Both optical and transmission electron microscopy results, reported in Craig et al 
(2003), indicate an absence of embrittling phases at the extremes of these five alloys, 
i.e., in the base alloy and in the 10wt% platinum alloy.  Optical micrographs are shown 
in Figure 20 (0wt% platinum) and Figure 21 (10wt% platinum) for the as-cast 
structures; bright field micrographs of the annealed structures are shown in Figure 22 
(0wt% platinum) and in Figure 23 (10wt% platinum).  Other than the expected fine 
aluminides and silicates typical of stainless steel and allowed by ASTM F139-00, both 
optical and bright field micrographs indicate the 10wt% platinum alloy contained coarse 
manganese-chromium oxides; no further investigation of these precipitates was pursued 
since these are considered typical of the manufacturing process for stainless steel. 
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 Figure 20 As-cast microstructure of 0wt% platinum showing cellular austenite (light 
areas) and skeletal ferrite (dark areas).  Electrolytically etched in oxalic acid.   
(Craig et al, 2003) 
 
 
 
Figure 21 As-cast microstructure of 10wt% platinum showing cellular austenite (light 
areas) and skeletal ferrite (dark areas).  Electrolytically etched in oxalic acid.   
(Craig et al, 2003) 
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Figure 22 Annealed microstructure of 0wt% platinum sample showing equi-axed grains 
of austenite.  Etched in Behara’s No. 3.  (Craig et al, 2003) 
 
 
 
Figure 23 Annealed microstructure of 10wt% platinum sample showing equi-axed 
grains of austenite.  Etched in Behara’s No. 3.  (Craig et al, 2003) 
 
 72
4.3.3.4 Mechanical properties 
     Calculated and experimental ultimate tensile and yield strengths for the 0-10wt% 
platinum specimens described in Table 21 are shown in Table 24.  The experimental 
data were obtained in a manner similar to that described in §4.2.3.4; calculations were 
by application of the Nordberg equations, Equation 10 (tensile) and Equation 11 (yield), 
using the assumed values as noted in §4.2.3.4, i.e., grain size 0.0449mm and 0% ferrite 
(since the tensile specimens were all tested in the fully annealed condition).  Physical 
property data are shown in Table 25, along with experimental data shown in Table 24. 
 
Table 24 Strength calculations for UNS S31673 and platinum-containing alloys  
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Table 25 Mechanical and physical property data for UNS S31673 and platinum-
containing alloys (0-10wt%)(Craig et al, 2003) 
 
Sample ASTM F139-00 0wt% Pt 1wt% Pt 3wt% Pt 6wt%Pt 10wt% Pt
 
UTS 
MPa 
 
490 
 
650 
 
604 
 
703 
 
660 
 
704 
YS 
MPa 
 
190 
 
274 
 
250 
 
347 
 
297 
 
355 
Elongation  
% 
 
40 min. 
 
60 
 
55 
 
55 
 
67 
 
52 
Hardness 
Rockwell B 
 
95 max. 
 
62.5 
 
73.5 
 
73.9 
 
70.8 
 
74.2 
 
 
     In Table 24, average calculated yield strength lags experimental yield strength by 
approximately 1%.  The average calculated ultimate tensile strength lags the 
experimental ultimate tensile strength by 18%.  In Table 25, the 10wt% platinum alloy 
is approximately 8% greater in ultimate tensile strength than the 0wt% platinum alloy 
(base); yield strength at 10wt% platinum is almost 30% greater than at 0wt% platinum.  
Discounting the 6wt% platinum hardness reading, which appears anomalous, as does its 
elongation, a gradual decline in elongation is accompanied by a similar increase in 
hardness from 0wt% to 10wt% platinum; both accompany the increases in strength. 
4.3.3.5 Corrosion 
     No corrosion testing was completed on these alloys.  The calculated pitting 
resistance equivalent number is as shown in Table 26.  All alloys exceeded the ASTM 
F139-00 requirement of being equal to or greater than 26. 
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Table 26 Pitting resistance equivalence number calculation for 5-6wt% platinum alloys 
(top row: IVT 37, second: IVT 38; third: IVT 66; fourth: IVT 78; fifth: IVT 79; bottom: 
BioDur® 316LS) 
 
Target 
 
Equation 12 
 
Result 
0wt% Pt 
Σ (19.70wt% Cr + 3.3 
(2.62wt% Mo) 
PREN = 28.3 (=/> 26 req. by 
ASTM F139) 
1wt% Pt 
Σ (18.20wt% Cr + 3.3 
(2.55wt% Mo) 
PREN = 26.6 (=/> 26 req. by 
ASTM F139) 
3t% Pt 
Σ (18.30wt% Cr + 3.3 
(2.55wt% Mo) 
PREN = 26.7 (=/> 26 req. by 
ASTM F139) 
6t% Pt 
Σ (18.40wt% Cr + 3.3 
(3.07wt% Mo) 
PREN = 28.5 (=/> 26 req. by 
ASTM F139) 
10wt% Pt 
Σ (19.20wt% Cr + 3.3 
(3.01wt% Mo) 
PREN = 29.1 (=/> 26 req. by 
ASTM F139) 
 
 
4.3.3.6 Radiopacity 
4.3.3.6.1 General 
     Both calculated and experimental radiopacity data are required because the 
calculated or ‘theoretical’ radiopacity data used to predict outcomes is based on single-
beam theory, §2.4, rather than the wide-beam (white radiation, or bremsstrahlung) 
concepts applicable to industrial (and medical) x-ray machines such as are used here.  A 
half-value-layer approach, described below, allows a narrowing of the wide-beam 
radiation, termed ‘hardening’ the beam, to better approximate the radiopacity results 
obtained with single-beam radiation. 
     As shown in Equation 5, component thickness has a dramatic effect on radiopacity, 
thus only foil with a thickness comparable to that of a typical tube from which a 
balloon-expandable coronary stent is made is of value for comparative purposes.  To 
obtain such data, all five of the 0-10wt% platinum alloys were rolled in a jewellers’ mill 
in an attempt to approximate 0.127mm, which is typical of stent tubing wall thickness. 
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4.3.3.6.2 Methodology 
     The overall intensity of an x-ray white radiation (bremsstrahlung) spectrum is the 
area under the spectral curve.  Intensity is determined by (a) peak kilovoltage, (b) tube 
(filament) current, (c) atomic number of the target material, and (d) filtration.  Peak 
kilovoltages used during deployment of coronary stents are typically 80kV to 100kV.  
Medical x-ray systems typically use three-phase or ‘constant potential’ generators; the 
industrial x-ray system used here, the Pantak Model HF 420CP, is such a system and 
generates a spectrum typical of a medical x-ray system; this system, located in the 
Radiation Physics Division at United States National Institute of Standards and 
Technology, in Gaithersburg, Maryland, has the advantage that its spectrum has been 
well-characterised.  A tungsten target is used and x-rays formed at the target exit the 
tube through a 7.0mm beryllium window, which allows unimpeded flow of the radiation 
above approximately 10keV and allows the vacuum in the tubehead to be maintained.  
The inherent filtration of the spectrum is thus defined by the tungsten target and the 
beryllium window.  A second industrial x-ray system, a Philips Model MG 161, also a 
constant potential generator with a tungsten target and a 1.0mm beryllium window (and, 
normally, a 3.0mm aluminium inherent filter, which was removed for this work), was 
used to obtain film data since no film processing capabilities were available at National 
Institute of Standards and Technology; this system is located in the non-destructive 
testing facility at United States Naval Surface Warfare Centre, located in Carderock, 
Maryland, along with a Kodak Model B automatic film processor. 
     The approach to determine radiopacity that has been used here is that defined in the 
ASTM International standard for radiopacity of plastics used for medical devices, 
ASTM F640-79 (reapproved 2000); no comparable standard was found for metals. 
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     Additional inherent filtration of 2.5mm aluminium, UNS A91100 or ISO Al990Cu, 
is required by ASTM F640 in order to remove the low energy long wavelength radiation 
that is passed by beryllium windows typical of x-ray tubes.  This will shift the intensity 
peak towards the peak kilovoltage, thus hardening the x-ray spectrum. 
     With the additional inherent filtration in place on both the Pantak Model HF 420CP 
and the Philips Model MG 161, the long wavelength spectrum was further hardened by 
use of additional aluminium of half-value-layer (HVL) thickness.  This filtration 
reduced the intensity by one-half at the point it entered the metal foil samples but also 
removed additional long-wavelength radiation and made the wide-beam radiation from 
the x-ray tube better approximate the single-beam radiation used to calculate expected 
radiopacities in §3.4, which used data from the National Institute of Standards and 
Technology web site (Hubbell and Seltzer, 1997).  Radiation measurements were made 
at 122cm from the x-ray source with an MDN Model 1015 x-ray monitor instrument 
and a Radcal ionization chamber.  Using a series of aluminium shims, the thickness was 
increased until the half-value-layer aluminium thickness was determined for both 
energies (3.2mm at 80kV; 4.1mm at 100kV).  The x-ray spectrum for 80kV with and 
without the half-value layer filtration is shown in Figure 24 (Seltzer, 2003); comparable 
x-ray spectra for 100kV are shown in Figure 25.  The removal of long-wavelength 
radiation is seen to shift the peak intensity towards the maximum energy level.  The 
characteristic peaks typical of tungsten targets appear at approximately 57.9kV-59.3kV 
(K-L transition) and at approximately 66.9kV-69.0kV (K-M transition) (Attix, 1986). 
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Figure 24 80kV x-ray spectra with and without half-value-layer filters (Seltzer, 2003) 
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Figure 25 100kV x-ray spectra with and without half-value-layer filters (Seltzer, 2003) 
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     ASTM F640, which has not been modified since 1979, relies on use of transmission 
film density only to ascertain radiopacity.  In Method A, used here, transmission film 
density (Equation 1) was determined for the metal foil sample and for an area on the 
film adjacent to the metal foil sample from the processed film; a Macbeth transmission 
densitometer, Model TD-100A, calibrated using a density strip, Quantalog TD1094A, 
was used.  Kodak Type M film was exposed to the radiation produced by the Philips 
Model MG 161 with the inherent aluminium filtration removed and replaced with the 
2.5mm aluminium filter required by ASTM F640, described above, and additional half-
value-layer filtration, also as described above.  The source-film distance was 122cm. 
Since transmission film densities are the common logarithms of the ratios of impinging 
versus transmitted intensities of light radiation, the characteristic curve for Kodak Type 
M film processed in a Kodak Model B automatic film processor, Figure 26, was used; 
processing was conducted at a temperature of 26.6°C and a cycle time of 12 minutes.  
The log relative exposure corresponding to the density measurement is found and the 
antilog of that value taken to obtain exposure.  The radiopacity of the film, which in 
ASTM F640 Method A is effectively considered that of the metal sample, is obtained by 
dividing the exposure found on the fully exposed film adjacent to the metal foil by the 
exposure of the metal foil sample.  Note that inaccuracies in measurement of thickness 
and in repeating radiopacity measurements are thought to amount to errors in 
experimentally-determined radiopacity data on the order of plus or minus ten percent.  
In addition, use of attenuation coefficient data at 80keV unfortunately means there is an 
inherent error involved due to the overlap with the platinum absorption edge at 80keV. 
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Figure 26 Manufacturer-supplied characteristic curves for industrial and medical film 
(Eastman Kodak Company, 2003) 
 
          The trend since the time ASTM F640 was written in the late 1970’s has been 
towards computed radiography systems, those in which x-ray systems use film-less 
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techniques.  Two systems are described below, including results, which are compared 
with those obtained from transmission film densities, as described above. 
     An amorphous silicon flat panel, the dpix FlashScan 30, now marketed by Varian 
Associates, which is sensitive to visible light rather than x-rays, was used with a 
gadolinium oxy-sulphide phosphor screen, brand name Kodak Lanex Fine.  The 
digitised output of the dpix panel is in pixels and is converted through a Digitome 
volumetric image system from a 12-bit to an 8-bit image by dropping the least 
significant four bits from the image pixel value, resulting in what is termed a linear 
renormalisation of the data stream by the manufacturer (Digitome Corporation). 
     The second digital system, used only to obtain data to validate the dpix-Digitome 
system, is a Science Applications International Corporation (SAIC) Digital Radioscopy 
System, DRS-2, which has as its imager a proprietary IM-810D charge-coupled device 
(CCD camera) and phosphor screen.  This system is sold principally to security 
organisations, thus limited technical details were available.  The output, as with the 
dpix-Digitome flat panel system, is a digital image; system output is in pixel values.   
     In both the dpix-Digitome and SAIC DRS-2 systems, digitised outputs were 
analysed by a commercial imaging software package, Image-Pro® Plus.  The number of 
pixels from the area that is imaged adjacent to the metal foil is divided by the number of 
pixels from the metal foil that is imaged simultaneously in order to obtain a non-film 
equivalent to the ASTM F640 Method A determination of radiopacity.  The maximum 
variation in linearity for the dpix-Digitome system was determined over a 13X range in 
detector exposure to be within 4 percent; variations in exposure were caused by 
changing time of exposure.  For the SAIC DRS-2 system, the variation over a 6X range 
in detector exposure, again varying only time, was determined to be within 3 percent. 
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4.3.3.6.3 Radiopacity results 
     The wide-beam radiopacities reported by Craig et al (2003) were taken earlier, 
without benefit of either the 2.5mm aluminium required by ASTM F640 or the 
additional half-value-layer aluminium, thus the results reported there for the 0.127mm 
samples are from a partially saturated detector.  The results are shown in Table 27 and 
Table 28; these tables also include both the wide-beam and single-beam radiopacities. 
 
Table 27 Wide-beam (80kV) and single-beam (80keV) radiopacities for five alloys 
 
Foil 
sample 
25mm x 
25mm 
Amor-
phous 
silicon 
Type 
M 
Film 
CCD 
camera 
Amor-
phous 
silicon + 
Al HVL 
filter 
Type M 
Film + 
Al HVL 
Filter 
CCD 
camera + 
HVL 
Filter 
Narrow 
beam 
(calcu-
lated) 
80keV 
0wt% Pt 1.39 1.43 1.38 1.27 1.34 1.27 1.06 
1wt% Pt 1.41 1.45 1.36 1.28 1.38 1.28 1.08 
3wt% Pt 1.42 1.46 1.38 1.30 1.34 1.31 1.09 
6wt% Pt 1.47 1.55 1.44 1.37 1.41 1.38 1.13 
10wt% Pt 1.52 1.59 1.49 1.39 1.45 1.40 1.17 
 
Table 28 Wide-beam (100kV) and single-beam (100keV) radiopacities for five alloys 
 
 foil 
sample 
25mm x 
25mm 
Amor-
phous 
silicon
Type 
M 
Film 
CCD 
camera 
Amor-
phous 
silicon + 
Al HVL 
filter 
Type M 
Film + 
Al HVL 
Filter 
CCD 
camera + 
HVL 
Filter 
Narrow 
beam 
(calcu-
lated) 
100keV 
0wt% Pt 1.38 1.28 1.26 1.21 1.18 1.17 1.04 
1wt% Pt 1.40 1.32 1.27 1.22 1.19 1.20 1.05 
3wt% Pt 1.41 1.29 1.30 1.24 1.19 1.23 1.06 
6wt% Pt 1.48 1.36 1.32 1.28 1.27 1.24 1.08 
10wt% Pt 1.51 1.41 1.36 1.32 1.33 1.29 1.10 
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4.3.4 Summary 
     As in §4.2, platinum was used to demonstrate that the concepts derived from the 
solubility approach are predictable.  In a similar manner, radiopacity is calculated using 
single-beam radiation and measured using a hardened wide-beam radiation. 
     Neglecting the 1-6wt% platinum alloys, Table 29 summarises the data at the two 
extremes of the 0-10wt% platinum experiment (0wt% platinum and 10wt% platinum). 
 
Table 29 Summary of 0wt% platinum and 10wt% platinum data for 0-10wt% alloys 
 
 
 
Sample/Parameter
 
 
UTS 
(MPa) 
 
 
Elon-
gation
(%) 
 
 
PREN 
(pitting 
resistance)
 
 
As-
cast 
ferrite* 
(%) 
 
Calculated 
radiopacity: 
HVL 
100keV 
 
Measured 
radiopacity: 
HVL 
100kV 
film/avg**
0wt% platinum 650 60 28.3 3.9/4.0 1.04 1.18/1.19 
10wt% platinum 704 52 29.1 0.0/0.0 1.10 1.33/1.31 
* measured/predicted  **average of results from both digitised detector systems 
 
 
4.4 Non-conforming, high-radiopacity button melts ( 0-35wt% platinum)
4.4.1 Introduction and approach
     The third and final button-furnace stage was designed to extend the radiopacity 
measurements to just beyond the 32.5wt% platinum limit described in §3.2, Table 8 
(80keV) and Table 9 (100keV).  The 32.5wt% platinum level was calculated based on 
allowing a pentanary alloy to achieve a 30% increase in radiopacity.  Based on 
experience with the 0-5wt% platinum alloys (§4.2), which added platinum only to 
BioDur® 316LS, and the 0-10wt% platinum alloys (§4.3), which created a UNS S31673 
alloy from elements, maintaining the required composition while adding platinum, it 
was determined a more consistent composition could be realised by remelting BioDur® 
316LS, adding platinum, chromium, and molybdenum.  Nickel was allowed to diminish 
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naturally in this experiment since platinum has a replacement value on the order of 2:1, 
as noted in (§3.3), and thus would maintain a minimum equivalency of 13wt% nickel, 
although the total nickel equivalent (nickel plus half platinum) would quickly exceed 
the upper specification limit established for these alloys, 15wt% nickel. 
     To aid in predicting outcomes, particularly when making a number of high-platinum 
alloys, which are quite costly, Table 30 shows a series of hypothetical or idealised UNS 
S31673 alloys that rigidly maintain the required elements at the centres of their 
respective ranges and silicon, manganese, and copper below their maximum values, 
both required and specified elements being in accordance with the requirements defined 
in ASTM F139-00.  In these alloys, only iron varies as platinum is added, while in the 
hypothetical alloys of Table 31, nickel also varies, decreasing by 0.85wt% with each 
5wt% increase in platinum, an amount taken away from iron content shown in Table 30. 
 
Table 30 Composition of idealised 0-35 wt% platinum alloyed in UNS S31673 (in wt%) 
(iron diminishes an equal amount with increasing platinum) 
 
alloy/element Pt Fe Cr Ni Mo Si Mn Cu 
UNS S31673 
base 
 
- 
 
63.75 
 
18.00 
 
14.00 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
S31673 
+ 5 Pt 
 
5 
 
58.75 
 
18.00 
 
14.00 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
S31673 
+ 10 Pt 
 
10 
 
53.75 
 
18.00 
 
14.00 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
S31673 
+ 15 Pt 
 
15 
 
48.75 
 
18.00 
 
14.00 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
S31673 
+ 20 Pt 
 
20 
 
43.75 
 
18.00 
 
14.00 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
S31673 
+ 25 Pt 
 
25 
 
38.75 
 
18.00 
 
14.00 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
S31673 
+ 30 Pt 
 
30 
 
33.75 
 
18.00 
 
14.00 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
S31673 
+ 35 Pt 
 
35 
 
28.75 
 
18.00 
 
14.00 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
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Table 31 Composition of idealised 0-35 wt% platinum alloyed in UNS S31673 (in wt%) 
(both iron and nickel diminish with increasing platinum) 
 
alloy/element Pt Fe Cr Ni Mo Si Mn Cu 
UNS S31673 
base 
 
- 
 
63.75 
 
18.00 
 
14.00 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
S31673 
+ 5 Pt 
 
5 59.60 
 
18.00 13.15 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
S31673 
+ 10 Pt 
 
10 55.45 
 
18.00 12.30 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
S31673 
+ 15 Pt 
 
15 51.30 
 
18.00 11.45 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
S31673 
+ 20 Pt 
 
20 47.15 
 
18.00 10.60 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
S31673 
+ 25 Pt 
 
25 43.00 
 
18.00 9.75 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
S31673 
+ 30 Pt 
 
30 38.85 
 
18.00 8.90 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
S31673 
+ 35 Pt 
 
35 34.70 
 
18.00 8.05 
 
2.625 
 
0.375 
 
1.00 
 
0.250 
 
 
     When the compositions of the idealised alloys in Table 31 are placed in the New 
PHACOMP model, it is found, as shown in Table 32, that the Md(avg) for the 35wt% 
platinum alloy is 0.929eV (1250°C), well in excess of the 0.920eV (1100°C) used in the 
previous experiments.  It is seen that the Md(crit) of 0.920eV intersects between 20wt% 
platinum (Md = 0.919eV ) and 25wt% platinum (Md = 0.921eV) for these hypothetical 
alloys.  As a result, two Md(crit) values are shown in Table 32, with the upper 
arbitrarily set at 0.929eV, the Md(avg) of the 35wt% platinum alloy. 
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Table 32 New PHACOMP results for optimised 0-35wt% platinum alloys with iron and 
nickel diminishing as platinum content increases 
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4.4.2 Experiment 
     Again using the processing approach described in §4.2.2, a large button furnace 
backfilled with argon was used to prepare the parallel to the eight hypothetical 
specimens shown in Table 30; these were prepared in 2.5wt% platinum increments up to 
15wt% and, after that, in 5wt% platinum increments.  As noted in §3.3, platinum has 
approximately one-half the austenitising effect of nickel, thus no attempt was made to 
replace nickel as the additions of platinum to the BioDur® 316LS base alloy depleted 
nickel content.  Chromium and molybdenum were added to maintain the pitting 
resistance equivalent number at equal to or greater than 26, as required by ASTM F139-
00.  Samples that were rolled and annealed at 1100°C were submitted for x-ray 
diffraction analysis.  Small specimens, approximately 100g, were cold-rolled in a 
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jeweller’s mill to approximately 0.127mm and annealed at both 915°C and 1100°C to 
be used for analysis using transmission electron microscopy, energy dispersive x-ray 
spectroscopy, and also as radiopacity specimens.   
4.4.3 Results 
4.4.3.1 Compositions of matrices and precipitates 
     The chemical compositions of the eleven specimens as determined by x-ray 
diffraction (described in §4.2.3.1) and energy dispersive x-ray spectroscopy are shown 
in Table 33; the latter, as noted above, was based on foil samples of the alloys annealed 
at both 915°C and 1100°C.  In the energy dispersive spectroscopy method, quantitative 
standardless analysis was performed, employing the Mott/Massy model for the 
scattering cross-section.  The structure of all alloys was found to be fully austenitic at 
both annealing temperatures.  Any residual ferrite in the fully annealed condition, if 
present, could not be detected against the background radiation.   
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Table 33 Composition of specimens containing 0-35wt% platinum using x-ray 
diffraction (top row) and energy dispersive spectroscopy (centre and bottom rows).  Top 
and bottom rows: annealed at 1100°C; centre row: annealed at 915°C.  
 
alloy/element 
(wt%) 
Pt 
 
Fe 
 
Cr 
 
Ni 
 
Mo 
 
Mn 
 
UNS S31673 
Base 
 
- 
 
62.8 
 62.1 
60.1 
17.5 
19.3 
20.0 
14.6 
14.1 
13.9 
2.8 
2.8 
3.7 
1.8 
1.7 
1.8 
S31673 
+ 2.5 Pt 
 
2.6 
2.9 
2.7 
60.2 
59.6 
59.0 
17.6 
18.9 
19.6 
14.1 
13.5 
13.4 
3.0 
3.6 
3.7 
1.8 
1.7 
1.6 
S31673 
+ 5 Pt 
 
5.15 
6.3 
6.0 
58.9 
57.1 
55.9 
17.5 
18.9 
19.3 
13.4 
13.1 
12.9 
2.8 
3.1 
3.8 
1.7 
1.6 
1.6 
S31673 
+ 7.5 Pt 
 
7.5 
9.2 
8.9 
56.2 
55.0 
55.6 
17.8 
18.1 
18.3 
13.0 
12.8 
12.4 
3.07 
3.3 
3.3 
1.7 
1.4 
1.5 
S31673 
+ 10 Pt 
 
10.1 
11.6 
11.6 
54.6 
 54.9 
52.6 
17.8 
16.4 
17.8 
12.5 
12.5 
12.3 
3.1 
3.1 
3.7 
1.6 
1.4 
1.5 
S31673 
+ 12.5 Pt 
 
12.6 
15.1 
14.1 
52.4 
51.5 
51.3 
17.8 
16.7 
17.9 
11.9 
11.9 
11.7 
3.0 
3.2 
3.6 
1.5 
1.5 
1.4 
S31673 
+ 15 Pt 
 
15.04 
17.1 
17.0 
50.7 
 49.1 
48.2 
17.8 
17.7 
17.9 
11.5 
11.3 
11.6 
3.1 
3.4 
3.4 
1.5 
1.4 
1.4 
S31673 
+ 20 Pt 
 
18.8 
20.5 
22.7 
47.1 
44.9 
45.8 
17.8 
19.2 
17.4 
10.8 
10.7 
10.3 
3.0 
3.4 
3.3 
1.4 
1.2 
- 
S31673 
+ 25 Pt 
 
24.9 
25.5 
30.5 
43.4 
43.1 
38.3 
17.5 
17.3 
16.6 
9.6 
10.1 
9.6 
2.9 
3.1 
3.4 
1.3 
1.2 
1.2 
S31673 
+ 30 Pt 
 
29.4 
29.9 
35.2 
39.5 
40.9 
35.1 
17.6 
15.1 
16.2 
8.9 
9.7 
8.9 
2.9 
3.1 
3.2 
1.2 
1.1 
1.0 
S31673 
+ 35 Pt 
 
35.5 
37.6 
37.5 
34.5 
34.1 
32.9 
18.0 
16.0 
16.9 
7.8 
8.4 
8.1 
2.8 
2.9 
3.3 
1.0 
0.9 
0.9 
 
 
     The New PHACOMP results for the alloys in base through 35wt% platinum alloys, 
in 5wt% platinum increments, are shown in Table 34.  Compositions used are those 
found with x-ray diffraction (top row in Table 33). 
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Table 34 New PHACOMP results for 0-35wt% platinum alloys  
(jagged line: 1250°C; solid line: 1100°C) 
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     Four distinct precipitates were found in these alloys, using transmission electron 
microscopy and associated microdiffraction and energy dispersive x-ray spectroscopy.  
Two types of precipitate (A; B) first appeared in the base alloy and were restricted to 
alloys containing either up to and including 15wt% platinum (Type A) or up to and 
including 20wt% platinum (Type B); see Table 35 and Table 36.  One type of 
precipitate (Type C) appeared only in the 25wt% platinum alloy (Table 37); the fourth 
type of precipitate (Type D) only appeared in the 25-35wt% alloys (Table 38). 
     For the nominally 12.5wt% platinum alloy, Figure 27 is a bright field image of the 
matrix at 915°C and the Type A precipitates listed in Table 35, along with 
microdiffraction patterns for both; Figure 28 shows the energy dispersive spectroscopy 
spectra of the matrix at 915°C and corresponding the Type A and Type B precipitates. 
Again for the nominally 12.5wt% platinum alloy, Figure 29 is a bright field image of 
the matrix at 1100°C and the Type B precipitates listed in Table 36, along with 
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microdiffraction patterns for both; Figure 30 shows the energy dispersive spectroscopy  
spectra of the matrix at 1100°C and both Type A and Type B precipitates.  The Type A 
precipitates were found in foils annealed at 915°C but were not found in those annealed 
at 1100°C.  The Type B precipitates were found in both foils annealed at 915°C and 
those annealed at 1100°C, with the exception of the 20wt% platinum sample, which did 
not exhibit the Type B precipitate at the lower annealing temperature.   
 
Table 35 Composition of Type A precipitate found in 0-15wt% platinum alloys 
(top row: foil annealed at 915°C; bottom row: foil annealed at 1000°C) 
 
 
alloy/element 
 
Pt 
 
Fe 
 
Cr 
 
Ni 
 
Mo 
 
Mn 
 
UNS S31673 
base 
- 
- 
17.3 
- 
74.8 
- 
2.3 
- 
4.8 
- 
1.1 
- 
S31673 
+ 2.5 Pt 
- 
- 
19.1 
- 
72.1 
- 
3.1 
- 
5.1 
- 
0.5 
- 
S31673 
+5 Pt 
- 
- 
15.9 
- 
75.6 
- 
2.4 
- 
5.4 
- 
0.8 
- 
S31673 
+ 7.5 Pt 
2.5 
- 
18.1 
- 
71.5 
- 
2.6 
- 
4.9 
- 
0.7 
- 
S31673 
+ 10 Pt 
1.4 
- 
7.7 
- 
84.8 
- 
0.7 
- 
5.2 
- 
0.2 
- 
S31673 
+ 12.5 Pt 
3.2 
- 
13.5 
- 
75.3 
- 
2.1 
- 
5.4 
- 
0.4 
- 
S31673 
+ 15 Pt 
2.2 
- 
9.2 
- 
81.9 
- 
1.0 
- 
5.5 
- 
0.2 
- 
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Table 36 Composition of Type B precipitate found in 0-20wt% platinum alloys 
(top row: foil annealed at 915°C; bottom row: foil annealed at 1000°C) 
 
 
alloy/element 
 
Pt 
 
Fe 
 
Cr 
 
Ni 
 
Mo 
 
Mn 
 
UNS S31673 
base 
- 
- 
11.2  
11.2 
82.1 
81.6 
1.2 
1.2 
5.1 
5.5 
0.6 
0.6 
S31673 
+ 2.5 Pt 
- 
- 
11.6 
10.1 
81.9 
82.8 
1.2 
0.8 
5.0 
5.8 
0.6 
0.5 
S31673 
+5 Pt 
- 
- 
10.7 
10.4 
82.7 
82.8 
1.2 
1.1 
5.0 
5.5 
0.6 
1.0 
S31673 
+ 7.5 Pt 
1.7 
- 
11.4 
10.2 
80.2 
83.0 
1.3 
1.1 
5.2 
5.5 
0.2 
0.1 
S31673 
+ 10 Pt 
1.4 
- 
7.7 
8.1 
84.8 
85.6 
0.7 
- 
5.2 
6.1 
0.2 
0.2 
S31673 
+ 12.5 Pt 
1.6 
- 
7.6 
10.0 
85.1 
83.7 
0.8 
- 
5.1 
6.1 
0.1 
0.3 
S31673 
+ 15 Pt 
2.2 
- 
9.2 
8.4 
81.9 
84.9 
1.0 
1.0 
5.5 
5.5 
0.2 
0.3 
S31673 
+ 20 Pt 
- 
2.2 
- 
7.0 
- 
82.9 
- 
0.6 
- 
6.2 
- 
- 
 
 
Table 37 Composition of Type C precipitate found in 25wt% platinum alloy 
(top row: foil annealed at 915°C; bottom row: foil annealed at 1100°C) 
 
 
alloy/element 
 
Pt 
 
Fe 
 
Cr 
 
Ni 
 
Mo 
 
Mn 
 
UNS S31673 
base 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
S31673 
+ 20 Pt 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
S31673 
+ 25 Pt 
34.2 
28.7 
25.3 
34.2 
30.0 
17.2 
6.4 
8.0 
3.3 
6.0 
0.8 
5.9 
S31673 
+ 30 Pt 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
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Table 38 Composition of Type D precipitates found in 25-35wt% platinum alloys 
(top row: foil annealed at 915°C; bottom row: foil annealed at 1100°C) 
 
 
alloy/element 
 
Pt 
 
Fe 
 
Cr 
 
Ni 
 
Mo 
 
Mn 
 
UNS S31673 
base 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
S31673 
+ 25 Pt 
47.2 
- 
10.8 
- 
36.3 
- 
2.4 
- 
2.7 
- 
0.5 
- 
S31673 
+ 30 Pt 
49.5 
54.0 
8.1 
8.0 
37.5 
32.4 
1.8 
2.0 
2.6 
3.0 
0.5 
0.6 
S31673 
+ 35 Pt 
52.9 
49.7 
6.3 
6.4 
36.7 
39.2 
1.3 
1.4 
2.6 
2.9 
0.2 
0.3 
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 (a) 
matrix 
precipitates 
matrix 
 
 
 
 
(b) B = {110} 
 
(c) B = {110}? 
 
Figure 27 (a) Bright field image of the 915°C anneal matrix for 12.5wt% platinum alloy 
(light line is 1 micron), (b) corresponding microdiffraction pattern, and 
(c) microdiffraction pattern for Type A precipitates 
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 (a) (b) 
 
(c) 
 
Figure 28 Energy dispersive x-ray spectroscopy spectra for 915°C anneal 12.5wt% 
p  
 
latinum alloy. Typical (a) matrix; (b) Type B precipitate, and (c) Type A precipitate
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 (c) B = {110}? 
 
Figure 29 (a) Bright field image of the 1100°C anneal matrix for 12.5wt% platinum 
alloy (light line is 1 micron), (b) corresponding microdiffraction pattern, and 
(c) microdiffraction pattern for Type B precipitates 
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(a)  (b) 
 
Figure 30 Energy dispersive x-ray spectroscopy spectra for 1100°C anneal 12.5wt% 
platinum alloy. Typical (a) matrix, and (b) Type B precipitate 
 
     For the nominally 25wt% platinum alloy, Figure 31 is a bright field image of the 
matrix annealed at 915°C and the two types of precipitate found, one rod-like (Type C) 
and the other (Type D) irregular-shaped (or rounded), along with their corresponding 
microdiffraction patterns.  Figure 32 shows the energy dispersive x-ray spectroscopy 
spectra for the nominally 25wt% platinum alloy matrix (915°C) and its rod-like and 
irregular-shaped precipitates. 
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 Fcc grain 
matrix
precipitates
(a) 
 
 (b) B = {110} 
 
(c) B = {???}, rod  
(d) B = {110}, round 
 
 
Figure 31 (a) Bright field image of Type C (rod-like precipitate at upper left) and Type 
D (irregular-shaped) precipitates in 25wt% platinum alloy  (915°C anneal)(1 micron 
line); microdiffraction patterns for (b) matrix, (c) Type C and (d) Type D precipitates.  
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 (a) (b) 
 
(c) 
 
Figure 32 Energy dispersive x-ray spectroscopy spectra for 25wt% platinum in UNS 
S31673 alloy (915°C anneal).  (a) matrix; (b) Type C, and (c) Type D precipitates 
 
 
     Figure 33 shows bright field and dark field images of matrices containing Type D 
precipitates.  Figure 34 shows a typical energy dispersive x-ray spectroscopy spectrum 
for Type D precipitates. 
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 matrix 
precipitates 
matrix 
Matrix 
(a) 
 
(b) B = {110} 
 
(c) B = {112} 
 
 
Figure 33 (a) Bright-field image of 915°C matrix and Type D precipitates in 35wt% 
platinum alloy (bar is 1micron) and corresponding microdiffraction patterns for (b) 
matrix, and (c) Type D precipitates  
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(b) B = {112} 
  
(c) B = {112} 
 
 
Figure 34 (a) Bright-field image of 1100°C matrix and Type D precipitates in 35wt% 
platinum alloy (bar is 1micron) and corresponding microdiffraction patterns for (b) 
matrix, and (c) Type D precipitates  
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4.4.4 Radiopacity
4.4.4.1 Experiment 
     Table 31 and Table 33, in the previous section, defined the hypothetical alloys and 
the actual alloys produced by adding platinum to a UNS S31673 alloy, BioDur® 316LS, 
along with sufficient chromium and molybdenum to maintain the required pitting 
resistance equivalent number.  Nickel was allowed to diminish naturally since the added 
platinum more than made up for this in terms of nickel equivalent.  Table 39 shows the 
single-beam radiopacity expected for the hypothetical alloys at 80keV and 100keV, 
while Table 40 shows the single-beam radiopacity expected for the actual alloys, again 
at 80keV and 100keV. 
 
Table 39 Single-beam radiopacities for hypothetical 0-35wt% platinum alloys  
(t = 0.127mm) 
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Table 40 Single-beam radiopacities expected for actual 0-35wt% platinum alloys          
(t = 0.127mm) 
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     The foil samples of the eight alloys varying in 5wt% increments that were described 
in the previous section and in Table 33 were x-rayed at 80kV and 100kV using the 
Pantak Model HF 420CP x-ray system with added aluminium inherent filtration as 
required by ASTM F640, along with an additional half-value-layer of aluminium, as 
described in §4.3.3.6.2.  The dpix flat panel detector, Kodak phosphor screen, Digitome 
processor, and Image-Pro® Plus software were used to obtain radiopacity 
measurements, using the digital analogue to Method A of ASTM F640.  No 
radiographic film was used in these experiments to obtain radiopacity measurements.   
     Table 41 provides the measured thicknesses of the rolled foil, which varied widely 
due to the varying densities of the alloys, which also are shown in Table 41. 
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Table 41 Thickness and density of 0-35wt% platinum specimens 
Design Point Thickness Density 
 mm g/cc 
UNS S31673 base 0.104 7.83 
S31673 + 5% Pt 0.135 8.08 
S31673 + 10% Pt 0.099 8.35 
S31673 + 15% Pt 0.115 8.63 
S31673 + 20% Pt 0.135 8.86 
S31673 + 25% Pt 0.157 9.25 
S31673 + 30% Pt 0.152 9.58 
S31673 + 35% Pt 0.152 10.02 
 
4.4.4.2 Radiopacity results 
     Experimental results are shown in Table 42.  Table 42 provides both wide-beam and 
single-beam radiopacities for the samples, with the single energy (single-beam) 
radiopacities calculated using Equation 5.   
 
Table 42 Wide-beam (experimental) and single-beam (single-energy) radiopacities 
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     Because of the wide variation in thickness, it was difficult to compare the 
radiopacities, thus the experimentally determined radiopacity (Table 42), density and 
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thickness (Table 41) was used in Equation 5 to determine an effective linear absorption 
coefficient for each alloy.  Table 43 shows the 80kV experimental (wide-beam) data 
from Table 42 normalised to 0.127mm; Table 44 shows the 100kV experimental data 
normalised to 0.127mm.  Averaging results for 30wt% and the 35wt% platinum samples 
to obtain an approximate 32.5wt% platinum result yielded averaged radiopacities for 
those two alloys that were found to be 1.67 for 80kV and 1.57 for 100kV.  Radiopacity 
for the base (0wt% platinum) alloy at 80kV was 1.35, thus 1.67/1.35 indicated the 
increase in radiopacity over the base alloy was approximately 24% at 80kV.  At 100kV, 
the base radiopacity was 1.26, thus the increase in radiopacity at 100kV over the base 
was 1.57/1.26, again approximately 24%.  These results are summarised in Table 45. 
 
Table 43 Experimental results at 80kV normalised to 0.127mm thickness 
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Table 44 Experimental results at 100kV normalised to 0.127mm thickness 
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Table 45 Radiopacity of 0-35wt% platinum viewed as percent increase over base alloy 
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4.4.5 Summary 
     The experiment in §4.4 was carried out to address the production of alloys 
containing platinum up to and slightly in excess of that required to achieve the overall 
goal of a 30% increase in radiopacity over the base alloy whilst maintaining the alloy 
free of embrittling precipitates and as a stainless steel in accordance with the Unified 
National Standard, i.e., where iron is the predominant element. 
     The alloys were found to be fully austenitic when annealed at both 915°C and 
1100°C.  Two types of precipitate appeared first in the base alloy and, at between 
15wt% and 20wt% platinum, disappeared.  One type of precipitate was unique to the 
25wt% platinum alloy; another was unique to the 25wt% to 35wt% platinum alloy. 
     Radiopacity, for the equivalent of a 32.5wt% platinum alloy, was found to increase 
up to approximately 24% at both 80kV and 100kV, using non-film techniques. 
4.5 Conforming, low-radiopacity, induction-melted alloys
4.5.1 Introduction and approach
     Both the size and the quality of an ingot required for establishing production of 
tubing to be made into balloon-expandable coronary stents demand use of furnaces 
typical of commercial stainless steel-making practice; button furnaces are not suited to 
such production.  The commercial suppliers of implant-grade austenitic stainless steel 
typically make ingots that are a minimum of 125kg, an amount that would make 
sufficient tubing for a manufacturer of stents that might last for several years.  In order 
to justify its investment in the costs for producing ingots of such demanding quality, the 
supplier might envision selling the product to a number of stent manufacturers; this in 
turn could potentially take away the incentive of the stent manufacturer to invest in 
research and development because the marketing edge normally attributable to such 
 106
efforts would be lost.  These considerations led to the determination to (a) develop the 
manufacturing processes on a more modest scale than would be typical of or practical 
for commercial endeavours, limiting the ingot size to 50kg, and (b) retain control of the 
proprietary technology that ensued. 
     A further consideration that applied initially was that the coronary stents being 
produced were manufactured by a photo-etch process; it was not clear to those who had 
developed the etching process that it could be easily modified to accommodate the 
change from UNS S31673 alloys to a variant of those containing 32.5wt% platinum.  As 
a result, a more cautious approach was taken: to develop the required manufacturing 
processes based on a modest increase in both platinum content and radiopacity.  This in 
turn led to process development of 5-6wt% platinum alloys through a programme at the 
United States Department of Energy metallurgical laboratory, Albany Research Centre. 
4.5.2 Experiment 
     Alloys containing nominally 5-6wt% platinum were produced by adding platinum to 
Carpenter Technology’s BioDur® 316LS, a UNS S31673 alloy, supplied in bar form 
and certified to meet the requirements of ASTM F138-00 (rod and bar).  Additions of 
chromium and molybdenum were made to maintain the pitting resistance equivalent 
number at least equal to 26 (Equation 12).   
     The manufacturing process to make foil in preparation for making tubing for stents is 
shown in Figure 35 and was described by Dennis, Craig et al (2003).   
 
 
Figure 35 Block diagram of optimum alloy-foil production process  
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     The vacuum induction melting (VIM) process shown in Figure 35 began with 
accurately weighing the material for the melt, comprised of BioDur® 316LS bar cut to 
fit inside a melting crucible capable of holding sufficient material for a 50kg ingot.  The 
pieces of bar were placed inside the melting crucible and the platinum, chromium, and 
molybdenum were placed inside a small container just above the crucible from which 
the contents could be tipped into it after the pieces of bar were melted.  The furnace was 
closed and brought to a vacuum of approximately 0.02kPa.  Power was applied, 
bringing the power to the induction coils slowly to approximately 100kw over the 
course of one hour and the vacuum to approximately 0.13kPa whilst noting the 
condition of the rods through a sight glass.  Power was maintained at 100kw for 
approximately five minutes after it was seen the rods were fully melted in order to 
ensure melting and promote mixing, then reduced to 70kw.  The additional elements 
were then tipped into the melt.  After another five minutes at this power level, the power 
was reduced to nought and the alloy was tipped from the melting crucible into the 
receiving crucible.  After approximately three hours cooling under vacuum, air was 
admitted and the ingot was claimed.   
     A typical ingot made in this manner is shown in Figure 36; these ingots were 
approximately 15cm diameter by 30cm long and weighed approximately 50kg on being 
removed from the receiving crucible.  After the ingot was cropped and cleaned, 
approximately 75% of the total weight was available for further processing; scrap 
material was periodically sent to a precious metals reprocessing centre where up to 95% 
of the platinum was recovered, at minimal expense. 
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 Figure 36 Typical vacuum induction melting furnace stainless steel ingot and crucible 
(United States Department of Energy, Albany Research Centre, Albany, Oregon) 
      A further refinement of the ingot-making process was use of a vacuum arc remelt 
(VAR) furnace, a stage that follows the vacuum induction melting furnace, as shown in 
Figure 35.  Ingots processed in such a furnace are identified as VAR-produced; those 
ingots processed in only the vacuum induction furnace are identified as VIM-produced.  
The basis for using the vacuum arc remelt process was that an alloy with fewer of the 
naturally-occurring inclusions (oxides, sulphides, aluminides, and silicates) typical of 
the vacuum induction melting process could be realised.  Commercially available 
implant alloys such as BioDur® 316LS were advertised as triple vacuum arc remelted.   
     When VIM-produced ingots were made, the mechanically cleaned VIM-produced 
ingots were quartered, lengthwise, and those pieces were welded together under vacuum 
and used as consumable electrodes in the vacuum arc remelt process.  A typical process 
started with 0.004kPa vacuum, 26V, and 2400A, and these latter were quickly increased 
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to approximately 32V and 3900A.  As before, a cylindrical ingot of approximately 
15cm diameter was produced with length dimensions dependant upon the amount of 
good-quality alloy obtained from the VIM-produced ingot.  Before the VAR-produced 
ingot was further processed it was either radiographed or subjected to ultrasonic testing 
to determine its fitness for rolling, as it was not uncommon to find large shrink holes, 
requiring further remelt processing to obtain a sufficiently large, discontinuity-free ingot 
to continue the manufacturing process to the forge and rolling mills.  Following the 
vacuum induction and vacuum arc remelt processes, a typical VIM-produced ingot had 
a composition as shown in the top row below for IVT 65 in Table 46; that ingot, 
subjected to vacuum arc remelt, had a composition as shown in Table 46, bottom row. 
 
Table 46 Nominally 6wt% platinum enhanced radiopaque austenitic stainless steel 
before (top) and after (bottom) vacuum arc remelting (in wt%; n.d. = not determined) 
 
Pt Fe Cr Ni Mo Mn Cu Si C N O 
5.83 58.3 17.6 13.6 2.9 1.2 0.1 0.4 n.d. n.d. n.d. 
5.81 58.4 17.6 13.6 2.9 1.1 0.1 0.4 0.004 0.02 0.02 
 
 
     After casting, whether by vacuum induction melting alone or as a VAR-produced 
ingot, the mechanically cleaned ingot was sometimes hot upset in a forge, Figure 20, 
after bringing it to a hot-rolling temperature (typically 1230°C) in an open furnace.  
Hot-rolling took place in the rolling mill, Figure 19, configured as a two-high mill; the 
larger rolls of the two-high configuration provided the capability for approximately 15% 
reductions.  Reheating took place at 15-minute intervals to maintain the minimum 
temperature considered sufficiently high for hot-rolling (1040°C).  After a final anneal 
at 1040°C, the plate was prepared for cold-rolling; the two-high mill was re-configured 
as a four-high mill since better dimensional control was obtained with smaller rolls, 
although reductions were smaller.  Periodic anneals at 1040°C were made during cold-
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rolling operations to maintain ductility and to minimise martensitic transformations.  
Final cold-rolling thickness was on the order of 1.0mm (sheet).   
     Rolling of sheet to foil suitable for producing welded tubing for stent fabrication, 
described by Dennis, Craig, et al and shown in Figure 35 as using a Sendzimir® rolling 
mill, is not further described here since only plate or sheet from the two-high/four-high 
rolling mill, Figure 16, was subjected to testing here.  
4.5.3 ASTM F139 tests and results 
     The initial ingots were made by vacuum induction melting only and paralleled the 
original 5wt% platinum alloy made by button furnace processing, as described in §4.2 
and shown in Table 16.  These alloys are shown in Table 47 as ingots IVT 37 and IVT 
38, along with a sample of the BioDur® 316LS base material.   
 
Table 47 Composition of ingot IVT 37 and ingot IVT 38 (Covino, Craig et al, 2003) 
(top row: IVT 37; second: IVT 38; third: BioDur® 316LS base; bottom: ASTM F139) 
 
Pt Fe Cr Ni Mo Mn Cu Si C N O 
4.95 Balance 17.5 13.6 2.87 1.71 0.07 0.48 - - - 
4.78 Balance 17.5 14.2 2.89 .096 0.08 0.47 0.027 0.056 0.04
- Balance 17.6 14.8 2.81 1.80 0.09 0.45 0.018 0.025 0.01
- Balance 17-19 13-15 2.25-3 2max 0.5max0.75max0.03max 0.1max - 
 
 
     Second-generation alloys (VAR-produced ingots), nominally 6wt% platinum alloys 
that were subjected to both vacuum induction melting and vacuum arc remelting, are 
shown in Table 48 for ingot IVT 66 and in Table 49 for ingot IVT 78 and ingot IVT 79.   
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Table 48 Composition of ingot IVT 66  
(top row: IVT 66; second: BioDur® 316LS base; bottom: ASTM F139) 
 
Pt Fe Cr Ni Mo Mn Cu Si C N O 
6.04 Balance 17.7 13.5 2.84 0.99 0.09 0.39 0.004 0.018 0.02
- Balance 17.6 14.8 2.81 1.80 0.09 0.45 0.018 0.025 0.01
- Balance 17-19 13-15 2.25-3 2max 0.5max0.75max0.03max 0.1max - 
 
 
Table 49 Composition of ingot IVT 78 and ingot IVT 79 
(top row: IVT 78; second: IVT 79; third: BioDur® 316LS; bottom: ASTM F139) 
 
Pt Fe Cr Ni Mo Mn Cu Si C N O 
6.20 Balance 18.5 13.5 3.07 1.33 0.09 0.48 0.027 0.015 0.02
6.51 Balance 17.9 12.9 3.15 1.35 0.07 0.57 0.023 0.035 0.02
- Balance 17.6 14.8 2.81 1.80 0.09 0.45 0.018 0.025 0.01
- Balance 17-19 13-15 2.25-3 2max 0.5max0.75max0.03max 0.1max - 
 
 
     Pitting resistance equivalent numbers for the above alloys are shown in Table 50. 
 
Table 50 Pitting resistance equivalence number calculation for 5-6wt% platinum alloys 
(top row: IVT 37, second: IVT 38; third: IVT 66; fourth: IVT 78; fifth: IVT 79; bottom: 
BioDur® 316LS) 
 
Σ (17.5wt% Cr + 3.3 (2.9wt% Mo) PREN = 27.1 (=/> 26 req. by ASTM F139) 
Σ (17.5wt% Cr + 3.3 (2.9wt% Mo) PREN = 27.1 (=/> 26 req. by ASTM F139) 
Σ (18.0wt% Cr + 3.3 (2.9wt% Mo) PREN = 27.6 (=/> 26 req. by ASTM F139) 
Σ (18.2wt% Cr + 3.3 (2.9wt% Mo) PREN = 27.8 (=/> 26 req. by ASTM F139) 
Σ (18.5wt% Cr + 3.3 (3.1wt% Mo) PREN = 28.7 (=/> 26 req. by ASTM F139) 
Σ (17.6wt% Cr + 3.3 (2.8wt% Mo) PREN = 26.8 (=/> 26 req. by ASTM F139) 
 
     As reported in Covino, Craig et al (2003), ingot IVT 37 and ingot IVT 38 were both 
tested in accordance with Practice E of ASTM A262, as required by ASTM F139-00.  
Practice E of ASTM A262 was intended to determine susceptibility to intergranular 
corrosion associated with the precipitation of chromium-rich carbides.  The test 
according to this practice was comprised of (a) embedding the sample in copper 
granules and then being exposed for 24 hours to a boiling solution of 100g/L hydrated 
copper sulphate and 100 mL/L of concentrated sulphuric acid, and (b) bending the 
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exposed samples 180° over a mandrel with a diameter equal to the thickness of the 
samples and visually inspecting them for evidence of cracking at 20X magnification.  
Two plate samples from each heat were ground to a 120-grit finish; one of each heat 
was annealed at 1040°C and one of each heat was sensitised via a one-hour heat 
treatment at 675°C followed by air cooling.  No evidence of cracking was found at 20X 
magnification in the annealed or the sensitised samples for either heat. 
     Tensile specimens were made in accordance with ASTM E8M-01 for sheet and plate 
specimens, Code F3; tensile tests were completed on a universal test machine in 
accordance with ASTM E8M-01 requirements.  Figure 37 shows the stress-strain curve 
found in the longitudinal direction on ingot IVT 66 and on the BioDur® 316LS base, 
both annealed at 1050°C and water quenched.   
 
Figure 37 Stress-strain curve for ingot IVT 66 (annealed at 1050°C); and BioDur® 
316LS base (annealed at 1050°C and water quenched) 
 
 
     Mechanical properties of ingot IVT 79, annealed at 1050°C and water quenched, 
were obtained in the same manner as ingot IVT 66 and are shown in Table 51. 
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Table 51 Mechanical properties for ingot IVT 79 cold-rolled and annealed at 1050°C  
 
Requirement  ASTM F139-00 Experimental results 
Ultimate tensile strength 490 MPa (min.) 629 ± 1 MPa 
Yield strength (0.2% offset) 190 MPa (min.) 352 ± 19 MPa 
Elongation 40% (min.) 67 ± 2% 
Hardness 95 Rockwell B (max.) 88 Rockwell B 
 
 
 
     Metallurgical properties for ingot IVT 79 are shown in Table 52. 
 
Table 52 Metallurgical properties for ingot IVT 79 cold-rolled and annealed at 1050°C 
 
Requirement ASTM F139-00 Experimental results 
Grain Size (ASTM E112) 5 (min.) 10 
Ferrite Content  None @ 100X 0.0% 
Microcleanliness (ASTM E45A): 
• Sulphides 
• Alumina 
• Silicates 
• Globular oxides 
 
1.5 (max.)/1.5 (max.) 
1.5 (max.)/1.0 (max.) 
1.5 (max.)/1.5 (max.) 
1.5 (max.)/1.0 (max.) 
 
0.0/0.0 
0.0/0.0 
0.5/0.0 
0.5/0.0 
 
 
4.5.4 Summary
 
     The development of low-radiopacity alloys containing nominally 5-6wt% platinum 
by manufacturing processes comparable to those of commercial suppliers of implant-
grade UNS S31673 alloys was undertaken.   
     For nominally 5-6wt% platinum alloys, the addition of platinum prohibited them 
from being considered as compliant alloys in accordance with ASTM F139-00.  The 
alloys were initially produced by vacuum induction melting only and the production 
process was subsequently refined to include vacuum arc remelting.   
     The composition of the alloys was found to be well within specification limits, with 
the exception of added platinum, as shown for VIM-produced ingots IVT 37 and IVT 
38 in Table 47 and for VAR-produced ingots IVT 65 (Table 46), IVT 66 (Table 48), and 
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ingots IVT 78 and IVT 79 (Table 49).  These ingots all met the pitting corrosion 
resistance compositional requirements of ASTM F139-00, as shown in Table 50.   
     As described in Covino, Craig et al (2003), ingot IVT 37 and ingot IVT 38 were both 
subjected to and passed the intergranular stress corrosion cracking tests described in 
Practice E of ASTM A262.   
     Ingot IVT 79 was subjected to the mechanical and metallurgical tests of ASTM 
F139-00 and exhibited properties that were acceptable in accordance with the standard. 
4.6 Conforming, high-radiopacity, induction-melted alloy 
4.6.1 Introduction and approach 
 
     The ideal capstone experiment would have entailed preparing a VAR-produced 50kg 
ingot that was subject to and successfully completed all ASTM F139-00 requirements.  
The somewhat less-than-ideal experiment entailed remelting a VIM-produced 30wt% 
platinum alloy in a button furnace to add nickel, then subjecting that alloy (BSC 83A) to 
the full set of ASTM F139-00 requirements.  Radiopacity experiments were not made. 
4.6.2 Experiment 
     A nominally 30wt% platinum, VIM-produced ingot, BSC 83, was produced as 
described in §4.5.2, then a 200g ingot was prepared by adding nickel in a button furnace 
(§4.2.2) to produce BSC 83A, a compositionally compliant alloy in accordance with 
ASTM F139-00, again recognising that adding platinum invalidated full compliance 
with the standard.  After hot-rolling and cold-rolling, the resulting sheet was annealed at 
1100°C and water quenched. 
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4.6.3 ASTM F139-00 tests and results 
     Table 53 shows the chemical composition of BSC 83A, BioDur® 316LS, and ASTM 
F139-00 requirements; Table 54 shows the pitting resistance equivalent number 
calculated for BSC 83A and BioDur® 316LS.   
 
Table 53 Composition of ingot BSC 83A, BioDur® 316LS, and ASTM F139-00  
(top row: BSC 83A; middle: BioDur® 316LS; bottom: ASTM F139-00) 
 
Pt Fe Cr Ni Mo Mn Cu Si C N O 
29.3 33.27 18.4 14.1 3.06 1.28 0.17 0.51 0.030 0.12 - 
- Balance 17.6 14.8 2.81 1.80 0.09 0.45 0.018 0.025 0.01
- Balance 17-19 13-15 2.25-3 2max 0.5max0.75max0.03max 0.1max - 
 
Table 54 Pitting resistance equivalent number for BSC 83A and BioDur® 316LS 
 
Σ (18.4wt% Cr + 3.3 (3.1wt% Mo) PREN = 28.6 (=/> 26 req. by ASTM F139)
Σ (17.6wt% Cr + 3.3 (2.8wt% Mo) PREN = 26.8 (=/> 26 req. by ASTM F139)
 
 
     Table 55 shows the results from conducting Practice E of ASTM A262 for 
intergranular corrosion susceptibility, as described in §4.5.3, while Figure 38 shows a 
typical surface condition after the corrosion susceptibility test. 
 
Table 55 Intergranular corrosion susceptibility test results for BSC 83A  
(annealing at 1100°C and annealing and sensitising at 650°C; water quench) 
 
Condition Mass loss (mg/cm2) 180° Bend Test 
Annealed 0.00 No Cracks 
Annealed and Sensitised at 650°C 0.16 No Cracks 
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 Figure 38 Typical surface of BSC 83A after corrosion susceptibility tests  
     Tensile specimens prepared as described in §4.5.3 were prepared from BSC 83A 
sheet, annealed at 1100°C and water quenched.  The stress-strain curves for BSC 83A 
and BioDur® 316LS are shown in Figure 39.  Mechanical property data for BSC 83A 
was determined and is shown in Table 56. 
 
 
Figure 39 Stress-strain curves for BSC 83A and BioDur® 316LS  
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Table 56 Mechanical properties of ASTM F139-00 compared to BSC 83A  
(annealed at 1100°C and water quenched)  
 
Requirement ASTM F139-00 Limits Annealed (Longitudinal) 
Ultimate Tensile Strength 490 MPa (min.) 954 MPa 
Yield Strength (0.2% offset) 190 MPa (min.) 499 MPa 
Elongation 40% (min.) 46% 
Hardness 95 Rockwell B (max.) 96 Rockwell B 
 
     Table 57 shows BSC 83A passed all metallurgical requirements of ASTM F139-00  
in terms of grain size, ferrite content, and microcleanliness. 
 
Table 57 Metallurgical properties of ASTM F139-00 compared to BSC 83A  
Requirement ASTM F139-00  Experimental results 
Grain Size (ASTM E112) 5 (min.)  
Ferrite Content None @ 100X 0.0% 
Microcleanliness (ASTM E45) 
• Sulphides 
• Alumina 
• Silicates 
• Globular oxides 
Thin/Heavy 
1.5 (max.)/1.5 (max.) 
1.5 (max.)/1.0 (max.) 
1.5 (max.)/1.5 (max.) 
1.5 (max.)/1.0 (max.) 
Thin/Heavy 
0.0/0.0 
0.0/0.0 
0.0/0.5 
1.5/1.0 
 
4.6.4 Additional tests not required by ASTM F139-00 
     The composition of the matrix of nominally 30wt% platinum ingot BSC 83A was 
obtained using both x-ray fluorescence and standardless energy dispersive x-ray 
spectroscopy (§4.4.3.1); the results are shown in Table 58.  Figure 40 shows the energy 
dispersive spectroscopy spectra for the matrix of ingot BSC 83A. 
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Table 58 BSC 83A elements as determined for the matrix by x-ray fluorescence (XRF) 
and energy dispersive x-ray spectroscopy (EDS) 
 
Element Cr Ni Mo Fe Mn Pt 
  Specified   
ASTM F139 Minimum 17 13 2.25 ~33 0.0 - 
ASTM F139 Maximum 19 15 3 balance 2.0 - 
BSC 83A base (XRF) 18.4 14.1 3.1 33.3 1.3 29.3 
BSC 83A matrix (EDS) 16.6 14.1 2.6 33.6 1.2 32.1 
 
 
Figure 40 Energy dispersive spectroscopy spectra for ingot BSC 83A matrix 
 
     Only one type of precipitate was found in BSC 83A.  Five different precipitates 
found in ingot BSC 83A were analysed with energy dispersive spectroscopy in order to 
get an average value for their compositions; the average value is shown in Table 59.  
Figure 41 shows a typical energy dispersive x-ray spectroscopy spectrum for BSC 83A.   
 
Table 59 Average values of elements found in ingot BSC 83A precipitates 
 
Element Cr Ni Mo Fe Mn Pt 
     
BSC 83A precipitates (EDS) 39.2 2.6 2.1 6.5 0 49.7 
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Figure 41 Energy dispersive x-ray spectroscopy spectra for ingot BSC 83A precipitates 
 
 
4.6.5 Summary
     A small compliant ingot containing nominally 30wt% platinum was subjected to the 
full range of tests required by ASTM F139-00.  The alloy, with the exception of having 
added platinum, fully complied with all the requirements of the ASTM International 
standard that describes implant-grade UNS S31673 alloys.  The only precipitates found 
in this alloy contained approximately 50wt% platinum and 40wt% chromium. 
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Chapter 5 
DISCUSSION OF RESULTS 
 
     In this chapter, the results from the experimental chapters, both design (Chapter 3) 
and implementation (Chapter 4), will be discussed.  In addressing these results, there is 
a need to revisit the source and context of the problem, the administrative and economic 
concerns, and the objectives that were established to point towards solutions. 
     To compete in a newly-emerged technological arena such as balloon-expandable 
coronary stents, a strategic advantage was required.  Austenitic stainless steel was well- 
known as an engineering solution for this application. However, it had the second 
lowest radiopacity of any material being used, the nickel-titanium shape-memory alloy 
having the lowest.  To maintain the advantages of having a non-composite material for 
an application that typically requires plastic deformation during deployment, it was 
determined that increasing the radiopacity of stents made from the alloy required 
addition of one or more compatible elements that would increase the radiopacity by the 
desired amount.  Composite materials, whether fabricated by drawing, e.g., a cobalt 
alloy tube over a platinum wire, or coating the stainless steel struts of a stent with gold, 
may encounter problems based on differences in elastic modulus and/or yield strength 
between the two or more elements of the composite when it is plastically deformed.  It 
was further determined that, initially, addition of a single, substitutional element 
solution would be pursued and the limit of radiopacity increase that could be achieved 
by such an addition would be governed by one principal constraint: that the resulting 
alloy would remain, under ASTM E527 (Unified National Standard) guidelines, steel. 
For this to be so, the iron content (in weight per cent) should be higher than the content 
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of any other single alloying element. In addition to merely remaining classifiable as 
steel, the resulting alloy would meet all requirements of an implant-grade austenitic 
stainless steel utilised internationally for such applications, with the sole exception of 
having an unspecified additional element.  Minor differences between Composition D of 
ISO 5832-1 and its companion, BS 7252-1, and ASTM F138 and its companion, ASTM 
F139, did not detract from those goals. 
     To maximise radiopacity of the alloy within the constraints described meant that the 
specification chosen to adhere to, ASTM F139-00, had established boundary conditions 
that must be met, above and beyond the requirement for having iron as the principal 
element, as required by ASTM E527.  Those requirements were that (a) the chromium 
content of the resulting alloy must be between 17wt% and 19wt%, (b) nickel content 
must be between 13wt% and 15wt%, and molybdenum content must be between 
2.25wt% and 3wt%.  With iron, these required elements formed a quaternary alloy; 
diminishing iron to its minimum and adding a single element meant to increase 
radiopacity of stents fabricated from the alloy created a pentanary alloy.  The basis of 
the argument to stay within the context of ASTM F139-00 was that, based on 
experience with the largely government-led committees of ASTM International’s F04 
committee on medical devices and materials, changes to the documents would likely be 
accepted into practice if it could be shown that the criteria of acceptance had not 
changed upon addition of a single element not previously on the list of specified 
optional elements, e.g., manganese, copper, etc.  In turn, the government agency (United 
States Food and Drug Administration) would likely be more convinced of the 
acceptability of allowing the previously unspecified additional element if the 
community it regulates had been involved throughout the proceedings required by 
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ASTM International for changing standards and, once the committee members had 
approved such an addition as both reasoned and safe, the change was balloted and 
approved by the entire voting membership.  The alternative, developing a new stent 
alloy, was not considered achievable within the context of the emergent requirements. 
     With the framework established of a pentanary alloy, and restricting the choices to a 
non-allotropic d-block element, the candidate elements were determined to be tantalum, 
tungsten, rhenium, osmium, iridium, platinum, and gold. 
     Tantalum and tungsten were eliminated primarily because, as body-centred cubic 
elements, the fragile balance of the face-centred cubic ‘austenite’ structure required to 
minimise ferromagnetism was lost.  The minimal size of the gamma loop in the binary 
with iron of both elements was used to predict this result.  At 100keV, both elements 
had failed to predict radiopacity increases of 130% or more that of the quaternary alloy. 
     Gold also was found to exhibit a minimal peritectic and eutectoid reaction with iron, 
indicating low solubility in iron.  Gold is known to exhibit high radiopacity when used, 
e.g., as radiopaque markers.  At the typical stent strut thickness utilised, 0.127mm, gold 
exhibited sufficient radiopacity increases at both 80keV (164%) and 100keV (134%). 
     The hexagonal close packed elements rhenium and osmium, in a binary alloy with 
iron, exhibited large gamma phase fields that predicted sufficient solubility to allow a 
130% increase in radiopacity at the two energy levels being utilised, 80keV and 
100keV.  The New PHACOMP modelling tool, however, eliminated these elements 
based on their Md(avg) exceeding Md(crit) at 1100˚C, i.e., a tendency to form σ phase. 
     Iridium, a face-centred cubic element, with an open field in its binary with iron, 
initially appeared suitable as a candidate fifth element in the pentanary, largely due to 
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its predicted radiopacity when used as a radiopaque stent.  However, using New 
PHACOMP modelling, iridium exhibited a slight tendency to form σ phase.  
     Platinum, also a face-centred cubic element, was found to have an open field in its 
binary with iron, like iridium.  Platinum, like gold and tantalum, has been used as a 
radiopaque marker on dilation balloons used to deploy balloon-expandable stents.  
Platinum has found wide application as an implant material, including use in a 
composite with a cobalt alloy for fabricating coronary stents.  New PHACOMP 
modelling predicted platinum would fall well below the Md(crit) for σ phase (Table 14).  
At 32.5wt% platinum, the resulting pentanary at 80keV predicted a 167% increase in 
radiopacity for a 0.127mm thickness (Table 8), while at 100keV a 135% increase was 
predicted (Table 9).  In addition, based on nickel equivalencies determined by Moema 
and Paton (2002), the Schaeffler diagram (Figure 13) predicted an increasingly stable 
austenite structure, contributing to the programme goal of minimising ferrite content.   
     Platinum was chosen as the candidate alloying element for subsequent experimental 
use.  It was the only element that offered both increased austenite stability and sufficient 
radiopacity to meet programme goals. 
     Moving from the concept of a pentanary alloy to the concept of staying within the 
framework of the international specification limits, with the exception of adding 
platinum to increase the overall radiopacity of stents made from the revised alloy, a 
proof-of-concept experiment with alloys containing 0-5wt% platinum was carried out. 
This was followed by experiments that used low-radiopacity alloys containing 0-10wt% 
platinum.  All these ingots were made in a button furnace.  X-ray diffraction results for 
both the 0-5wt% platinum alloys and the 0-10wt% platinum alloys indicated that up to 
10wt% platinum was easily accepted into solution and no new precipitates were formed.  
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Ferrite content was measured for the 0-10wt% platinum alloys and, in all except the 
base alloy, which had no added platinum, no ferrite was found, as had also been found 
to be the case when using x-ray diffraction.  Optical microscopy showed some minimal 
amount of skeletal ferrite in the as-cast structure (Figure 21), as compared to the base 
alloy (Figure 20), which exhibited somewhat more skeletal ferrite.  Annealed 
microstructures of both the base alloy and the 10wt% platinum alloy correlated well 
with both x-ray diffraction results and ferrite measurements of annealed specimens.  In 
the lower-radiopacity alloys, it was found that both yield and ultimate tensile strength 
increased as platinum content increased; hardness in these alloys increased slightly and 
ductility decreased slightly (Table 25). 
     With the higher-radiopacity (0-35wt% platinum) button furnace alloys, the 
composition of the four types of precipitates that were found in these alloys was 
determined.  Two of the precipitate types, described as Type A and Type B, were found 
in the UNS S31673 base alloy.  Type A was only found in alloys containing up to 
15wt% platinum and annealed at 915˚C; Type A precipitates had average chromium and 
iron contents of approximately 77wt% and 14%, respectively (Table 35).  Type B was 
found in alloys containing up to 20wt% platinum; Type B precipitates were found in 
alloys subjected to a low-temperature (915˚C) anneal up to 15wt% platinum and also 
were found in alloys subjected to a high-temperature (1000˚C) anneal, up to 20wt% 
platinum.  Type B precipitates, like the Type A precipitates, were determined to be 
principally chromium (average 83wt%) and iron (average 10wt%)(Table 36).  In both 
precipitates, molybdenum was consistently present at approximately 5wt%.  Beginning 
at 7.5wt%, a small amount of platinum was found, up to approximately 3wt%, in both 
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Type A and Type B precipitates.  The principal features of Type A and Type B 
precipitates are shown in Table 60. 
 
Table 60 Composition of precipitates found in base alloy 
 
Type/Element Chromium Iron Molybdenum 
Type A 77wt% 14wt% 5wt% 
Type B 83wt% 10wt% 5wt% 
 
 
     Type C precipitates were only found in the 25wt% platinum alloy.  This precipitate 
was found at both the 915˚C and the 1100˚C anneals (Table 37).  Platinum averaged 
31wt% in Type C precipitates, followed by iron (30wt%), chromium (24wt%), nickel 
(7wt%), and molybdenum (5wt%); manganese occurred at the 915˚C anneal at 
approximately 1wt% but occurred at approximately 6wt% for the same alloy at the 
1100˚C anneal.  The principal features of Type C precipitates are shown in Table 61. 
 
Table 61 Composition of Type C precipitates found only in 25wt% platinum alloy 
 
Platinum Iron Chromium Nickel Molybdenum 
31wt% 30wt% 24wt% 7wt% 5wt% 
10at% 35at% 30at% 8at% 13at% 
 
 
 
     Type D precipitates first were found beginning in the 915˚C anneal of the 25wt% 
platinum alloy and in both heat treatments of the 30wt% and 35wt% platinum button 
melt furnace alloys (Table 33).  Type D precipitates were also found in BSC 83A, a 
30wt% platinum alloy containing 14wt% nickel; BSC 83A was made from an induction 
 127
furnace ingot (BSC 83) that did not have nickel added to the melt when it was melted in 
an induction furnace; nickel was later added in a button furnace to lower the Md(avg).  
BSC 83A was annealed at 1100˚C.  In the 25wt% to 35wt% alloys (Table 38), platinum 
averaged 51wt%, followed by chromium (36wt%) and iron, which diminished from a 
high of 10.8wt% (25wt% platinum) to a low of 6.3wt% (35wt% platinum)(both with 
915˚C anneal).  Small amounts of nickel (up to 2.4wt%) and molybdenum (up to 3wt%) 
were also found in these precipitates.  In ingot BSC 83A, the Type D precipitate 
contained 49.7wt% platinum (compared to an average of 51wt%, as above), followed by 
chromium at 39.2wt% (compared to an average of 36wt%), iron at 6.5wt% (compared 
to an average of 8wt%), with nickel and molybdenum contents at levels comparable 
with the non-conforming 25wt% to 35wt% platinum button melt alloys.  The principal 
features of Type D precipitates are shown in Table 62. 
 
Table 62 Composition of Type D precipitates found only in 25-35wt% platinum alloys 
 
Type/Element Platinum Chromium Iron 
Non-conforming alloys 
25wt% - 35wt% 
  
 
~51wt% avg. 
(25at%) 
 
~36wt% avg. 
(61at%) 
 
~8wt% avg. 
(15at%) 
Conforming alloy 
30wt% 
  
 
~50wt% 
(23at%) 
 
~39wt% 
(63at%) 
 
~7wt% 
(14at%) 
     
     The significance of these precipitates was not evaluated in the 0-35wt% platinum 
button melt alloys since those were being used to study radiopacity and to determine 
whether precipitates were present.  However, the presence of both Type A and Type B 
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precipitates in the base alloy clearly indicated these precipitates were not the result of 
adding platinum.  The presence of the Type C precipitate in only the 25wt% platinum 
alloy was of interest but there was no opportunity to make another button to determine 
whether this was an artefact of the processing route or was truly unique to this alloy.  
     The presence of the Type D precipitate in the conforming 30wt% platinum alloy, as 
well as the non-conforming 25-35wt% platinum alloys, is also of interest.  In the 30wt% 
platinum conforming alloy, BSC 83A, hardness was just over the limit (96 versus 95 
Rockwell B), elongation was near the minimum (46% versus 40%), and both ultimate 
tensile strength and yield strength were extremely high (Table 56), i.e., 955MPa versus 
490Mpa minimum for ultimate and 499MPa versus 190MPa minimum for yield.  The 
Type D precipitate did not appear to manifest itself as deleterious in this tensile test.  
Similarly, in the corrosion susceptibility tests, both annealed and sensitised, there was 
no apparent effect of these precipitates since the alloy passed both 180° bend tests.  No 
annealing temperature greater than 1100°C was attempted to determine whether the 
precipitates would go into solution at greater annealing temperatures.  Processing of the 
30wt% platinum alloys was not considered a part of this research programme since this 
effort was taken over by a stent production organisation in anticipation of its use there; 
the 30wt% platinum alloys being investigated for production use are being made 
commercially at this writing, with plans to complete transmission electron microscopy 
and energy dispersive x-ray spectroscopy analysis of the ingot and the seamless tubing 
that is to be made from the ingot to determine whether Type D precipitates are present. 
     BSC 83A was subjected to and passed all tests required to comply with ASTM F139-
00.  The composition of the matrix and the calculated pitting resistance equivalent 
number were within specification, again with the exception of having an unspecified 
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added element, platinum (Table 53; Table 54).  The intergranular corrosion 
susceptibility test was passed in both the annealed and sensitised conditions (Table 55), 
as noted above.  Measured grain size and ferrite content in the annealed condition were 
acceptable, as were the inclusion contents of sulphides, aluminides, silicates, and 
globular oxides.  Yield and ultimate tensile strengths, again as noted above, were found 
to be quite high and hardness was found to be slightly in excess of the maximum but 
within ASTM F139-00 tolerances; elongation was determined to be 46%, just above the 
minimum required of 40%. 
     By comparison with the above, low-radiopacity, conforming, pre-production alloys 
made in the vacuum induction furnace were subjected to the same series of F139-00 
tests and, for ingot IVT 79, a nominally 6wt% alloy, yield and ultimate tensile strength 
were 352MPa and 629MPa, versus 499MPa and 954MPa, respectively, with BSC 83A.  
Hardness was 88HRB for IVT 79 versus 96HRB for BSC 83A; elongation for IVT 79 
was 67% (Table 51).  Grain size for ingot IVT 79, after pre-production hot- and cold-
rolling, was ASTM E112 size 10 (fine).  Ingot BSC 83A exhibited an ASTM E112 
grain size of 5 (minimum).  Ingot (button) BSC 83A was rolled in a small mill.  The 
annealing temperature for ingot IVT 79 was 1050˚C and, for ingot BSC 83A, 1100˚C.  
These key parameters are summarised below in Table 63. 
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Table 63 Comparison of conforming alloys at 6wt% and 30wt% platinum 
 
Alloy/Property 
Hardness 
(Rockwell B) 
Elongation 
 
Ultimate 
tensile strength 
Yield strength 
BSC 83A 
(30wt%) 
 
96 
 
46% 
 
954MPa 
 
499MPa 
IVT 79 
(6wt%) 
 
88 
 
67% 
 
629MPa 
 
352MPa 
ASTM F139 95 (max.) 40% (min.) 490MPa (min.) 190MPa (min.) 
 
     As noted above, radiopacity determination was primarily addressed through the 0-
35wt% platinum button melt alloys (Table 40).  Using x-ray diffraction data from Table 
33, which closely parallels the design set in Table 31, excellent agreement was found 
between single energy radiopacities (Table 39 compared to 40).  At 20wt% platinum, 
where only the Type B precipitates were found, the radiopacity increase at 80kV and 
100kV over the base alloy was approximately 16% and 13.5%, respectively.  At 30wt% 
platinum and 35wt% platinum, for an equivalent to a 32.5wt% platinum alloy, these 
increases averaged approximately 24% for both 80kV and 100kV.  Thus for the 
maximum 32.5wt% platinum alloy that maintained the definition of these alloys as steel 
these lower values would be the maximum experimentally determined radiopacity 
increase, rather than the 64% and 34% increases that were found using narrow beam 
calculations for the pentanary alloy at those same energy levels.  These data are 
summarised in Table 64. 
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Table 64 Radiopacity increases for 20wt% and (equivalent) 32.5wt% platinum alloys 
Alloy /  
Radiopacity increase 
80kV / 80keV 
(wide-beam / single-beam) 
100kV / 100keV 
(wide-beam / single-beam) 
20wt% platinum alloy 16% / 20% 14% / 11% 
32.5wt% platinum alloy 
(avg 30 & 35wt% data) 
24% / 42% 24% / 22% 
 
     As was shown in Table 45, summarised in Table 64 for the 20wt% platinum alloy 
and the average of the 30wt% and 35wt% platinum alloys, the increases in radiopacity 
for calculated (single-beam) versus experimental (wide-beam) were determined to be 
more dramatic for the 80keV versus 80kV than for the 100keV versus 100kV energies.  
Those differences are explained by noting that the single-beam calculations take into 
account the K-alpha of platinum, which is at 80keV, thus causing the calculated 
radiopacity at 80keV to be quite high and to increase with platinum content, as shown in 
Table 45.  At 20wt% platinum, the increase in single-beam radiopacity over the base 
alloy is 19% and the experimental increase over the base alloy is 16%.  At the averaged 
values of 30wt% platinum and 35wt% platinum, the equivalent 32.5wt% platinum alloy 
indicates a 42% increase over the base alloy for narrow beam radiopacity and only a 
24% increase over the base alloy for wide-beam radiopacity.  The explanation for this 
large differential lies, in addition to the greater weight percent platinum (at 32.5wt% 
versus 20wt%), in the hardened 80kV beam, which averages radiopacities both above 
and below the K-alpha into a single numeric value, which is substantially less than the 
peak found at the K-alpha.  With the 100keV data, there is less of a difference between 
the single-beam and the wide-beam radiopacities because this energy is well above the 
peak found at the platinum K-alpha. 
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Chapter 6 
CONCLUSIONS AND RECOMMENDATIONS 
 
Conclusions 
 
1. The New PHACOMP method, with its Md(avg) for individual alloys and with 
an experimentally determined Md(crit), provides a means to predict and to 
compare the propensity of alloys to develop deleterious phases (c.f., Table 32). 
2. Schaeffler plots can be modified by adding nickel or chromium equivalents (e.g., 
0.5 platinum for nickel) to predict ferromagnetic phases (c.f., Figure 13). 
3. Radiopacities of alloy foil determined by single-beam calculations compare well 
with radiopacities of alloy foil determined experimentally by wide-beam 
methods when (a) the large difference in intensity between the two methods is 
recognised, and (b) ratios are used rather than absolute numbers (c.f., Table 8, 
Table 9 for single-beam calculations; c.f., Table 43, Table 44 for wide-beam). 
4. Nordberg formulae for predicting strength are useful for zero platinum alloys but 
must be modified to be useful for alloys containing platinum (c.f., §3.4). 
5. Alloys containing up to 35wt% platinum are shown from Schaeffler to be free 
from ferrite and martensite and this is confirmed experimentally (c.f., §4.4.3). 
6. Alloys containing up to 20wt% platinum are shown from New PHACOMP to be 
free from precipitates which are not in the base alloy and this is confirmed 
experimentally (c.f., Table 32, §4.4.3). 
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7. Alloys containing greater than 20wt% platinum are shown from New 
PHACOMP to contain precipitates high in platinum and chromium that are not 
in the base alloy and this is confirmed experimentally (c.f., Table 32, §4.4.3). 
8. Both a nominally 6wt% platinum induction melted alloy (IVT 79) and a 
nominally 30wt% platinum button furnace melted alloy (BSC 83A) passed all 
ASTM F139-00 tests, thus a 20wt% platinum induction furnace alloy subjected 
to these tests should pass all these tests, as well (c.f., §4.5.4, §4.6.5). 
9. Increases in strength and hardness at the 20wt% platinum level are expected to 
be well above the base alloy but not as high as those found with the 30wt% 
platinum alloy (BSC 83A) that was subjected to and passed ASTM F139 tests. 
10. The average experimentally determined increase in radiopacity for a 20wt% 
platinum alloy at 80kV and 100kV was 16% (the programme goal was 15%); the 
average experimentally determined increase in radiopacity for a 32.5wt% 
platinum alloy is expected to be 24% (less than programme goal of 30%). 
11. Based on the above, a base alloy containing 20wt% platinum would provide 
sufficient radiopacity increase and should pass required ASTM F139-00 tests. 
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Recommendations for further work 
 
1. Computational thermochemistry should be used, if an appropriate database 
containing platinum can be found or developed, to provide a phase diagram that 
brings out the precipitate compositions as well as the austenite solubility limits. 
2. The source of the precipitate found beginning in the 25wt% platinum alloy and 
continuing through the 35wt% platinum alloy needs to be carefully analysed and 
characterised prior to adopting an alloy in this range for stent fabrication; the 
phase diagram obtained in (1) above should be used in such an analysis. 
3. The source of the precipitate at 25wt% platinum needs to be determined; if this 
is determined to be an artefact or anomalous finding, it may be possible to 
increase platinum content somewhat higher than the 20wt% referred to above.   
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